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Infections of normally sterile body fluids (SBF) including blood, cerebrospinal-, pleural-, 
peritoneal, – pericardial and synovial fluid are critical and require early diagnosis and rapid 
initiation of appropriate antimicrobial therapy. With the advanced and invasive care of 
modern medicine, infections of SBF are increasing worldwide. The clinical microbiology 
laboratory is crucial in facilitating targeted therapy through early microorganism detection, 
identification and antibiotic susceptibility testing. This actionable information will allow 
correct antimicrobial therapy early in the infectious process.  
 
Blood culture systems as well as blood culture bottles are the standard diagnostic method in 
blood cultures and are utilized for SBF cultures. The overall aim of this thesis was to evaluate 
and improve the microbiological diagnosis of SBF including blood from positive blood 
culture bottles.  
 
The first study focused on BacT/Alert Virtuo blood culture system introduced into the market 
to replace the BacT/Alert 3D blood culture system by the same company. The study presented 
in this thesis showed a significantly shorter time to detection for bottles incubated in the 
Virtuo system than those incubated in the BacT/Alert 3D system (median 12 h and 15 h, 
respectively; p < 0.0001) in simulated blood cultures.  
 
In Study 2, the performance a unique method of short-term culture followed by MALDI-TOF 
MS was analyzed prospectively. The study showed a successful identification of 424/515 
(82.3%) bacteria with MALDI-TOF MS after 5.5 h subculture on solid media.   
 
In Study 3 and 4, the FilmArray BCID panel was prospectively evaluated for accurate 
identification and limited antibiotic susceptibility testing. In Study 3, the FilmArray BCID 
showed accurate identification of microorganisms in 153/167 (91.6%) and 17/24 (71%) 
culture positive blood culture bottles with monomicrobial- and polymicrobial-growth. In 
Study 4, the performance of FilmArray BCID was analyzed for SBF other than blood. The 
assay could identify all microorganisms in 84/84 (100%) and 18/24 (75%) SBF samples with 
mono- and polymicrobial growth respectively. These studies showed that the FilmArray 
BCID panel is a reliable and fast method that may be utilized in blood cultures as well as 
other SBF that are cultured in blood culture bottles.  
 
 
In Study 5, the performance of four S. pneumoniae antigen tests including ImmuLexTM, 
SlideX® pneumo-Kit, WellcogenTM, and BinaxNOW® were evaluated. The study revealed 
similar sensitivity of 99.6%-100% for all tests when excluding invalid results in the 
calculation. However, the study showed that the BinaxNow® had the lowest specificity 
(64.1% 9, p<0.01) among the four methods. The ImmuLexTM test had lower specificity than 
the Slidex® test (82.6% vs 97.6%, p<0.01) and performed similar to the WellcogenTM test 
(84.5%, p=ns).  
 
In conclusion, the present thesis showed that the new Virtuo blood culture system allows 
faster detection of microorganisms in blood culture bottles. The thesis further presented 
several methods for rapid identification of microorganisms after detection of growth in blood 
culture bottles. These tests included FilmArray BCID panel and the latex agglutination tests 
directly from blood culture bottles while MALDI-TOF MS was performed after sub-culture 
on solid media. These rapid tests are important complements to the rigorous and extensive 
conventional culture methods and provide early critical actionable information for 
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Sterile body fluids (SBF), such as blood, cerebrospinal, pleural, peritoneal, pericardial and 
synovial fluid, are all susceptible for serious invasive bacterial and fungal infections. The 
advancement of modern medicine including invasive procedures has led to increased 
infections of normally sterile body fluids including blood1. Early detection and rapid 
identification of the microorganisms is critical for appropriate management and targeted 
antimicrobial therapy 1–5. The clinical microbiology laboratory is central in facilitating 
appropriate antimicrobial therapy in the management of SBF infections by confirming the 
presence of infectious pathogens, identifying them and providing antimicrobial susceptibility 
testing that allows targeted antimicrobial therapy. This thesis presents studies aimed at further 
improving the microbiological diagnosis of SBF infections including detection of 
microorganisms, identification and antibiotic susceptibility testing (AST) from positive 
blood culture bottles.   
 
1.1 DEFINITION OF INFECTIONS OF STERILE BODY FLUIDS  
 
The etiology of infections of SBF varies and may include surgery, trauma and burn injuries 
that introduce infectious pathogens to the normally sterile sites. Infection of each sterile site 
or SBF is separately defined and may describe the anatomical site, organ involved, etiology, 
clinical parameters/presentation and pathophysiology (e.g. bacteremia, sepsis, bacterial 
meningitis, bacterial peritonitis etc.). However, infection of SBF sites is in general associated 
with significant mortality and morbidity and need to be readily assessed and treated with 
appropriate antimicrobial therapy2,4–6. Initial antimicrobial treatment of suspected infection 
of SBF is guided by local microorganism susceptibility patterns as well as clinical societal 
guidelines and often includes using broad spectrum antimicrobials pending microbiological 
evaluation. In response to recommendations to limit the use of broad-spectrum antimicrobial 
therapy and the extended time to detection of the infectious pathogens, major research efforts 
have been placed in improving the microbiological analysis by decreasing time to detection, 






1.2 LABORATORY DIAGNOSIS OF INFECTIONS OF STERILE BODY FLUIDS  
 
1.2.1 Time to detection of microorganisms   
 
The first challenge encountered in the microbiological diagnosis of SBF is the ability to detect 
microorganisms causing the infection of the SBF. The microorganisms are often very low in 
number and uneven distributed in the SBF that require highly sensitive methods. The first 
methods developed for detecting infection in SBF were the manual culture systems. The first 
manual culture systems involved a broth-based culture method (monophasic) where the 
specimen was inoculated in the culture bottles with culture medium and manually inspected7. 
The manual culture system had the advantages of simplicity and for the laboratories to be 
able to produce their own blood culture vials. However, the manual system was labor 
intensive requiring venting the culture bottles to create an aerobic atmosphere, manual 
reading for culture growth that took time from doing other diagnostic work and the challenge 
to inspect them with the frequency required to give early detection of growth. The manual 
method was then further developed to include a biphasic method where the blood culture 
bottles contained both solid media as well as a liquid phase described by Castaneda et al., in 
1947 (Figure 1)8. The biphasic culture method was performed by inoculating the bottles and 
then processing the culture by modifying the air in the bottles, tilting to allow the fluid over 
the solid medium, incubate the bottles in upright position and examining the bottles visually 
on a scheduled time intervals8. Several other biphasic methods were developed with the most 
widely known biphasic method being the Septi-Chek. The Septi-Chek bottles were 
inoculated with blood and visually inspected twice for the first two days and then once per 
day until seven days of incubation had been completed7. The manual mono- and biphasic 
culture methods provided the foundation that allowed the development of the automated 





Figure 1. Display of mono- and biphasic blood culture bottles. 
 
 
Automated blood culture systems were developed in response to the aforementioned 
challenges in the manual culture systems with the purpose to minimize the technician hands-
on time for specimen processing while increasing the detection rate as well as decreasing the 
time to detection. The first blood culture instruments for automated detection were introduced 
in the 1970s and were based on the detection of increasing carbon dioxide (CO2) 
concentrations seen with microbial growth in culture bottles. One such early blood culture 
system was developed by Johnston Laboratories (now known as Becton Dickinson 
Diagnostic Instrument Systems) using broth media that contained radioactive 14C in blood 
culture bottles. During the microbial metabolism, the radioactive 14C was released as 14CO2 
into the headspace of the bottles. The bottles were analyzed for growth with a heat-sterilized 
needle, an aliquot was collected from the headspace and analyzed for radioactivity to assess 
for microbial growth7. Radioactive reagents are hazardous to the health and the environment 
and is a major disadvantage in any diagnostic method due to the challenges of using them as 
well as disposing them after use safely. In addition, the bottle heads had to be punctuated for 











In the 1980s, a new generation of blood culture systems were introduced with the 
development of infrared spectrophotometric CO2 detection. The new infrared based blood 
culture systems did not have the disadvantage of using radioactive substances. However, the 
system still required punctuation of the bottle head to collect gas for analysis, replacing 
removed gas and risking contaminating blood culture bottles9. These first automated 
detection of growth using CO2 in blood culture systems made manual inspecting of culture 
growth obsolete, but still required manual monitoring of growth via other methods that 
exposed the technicians to radioactive substances and/or risked contaminating the culture 
bottles as well as delaying the detection.  
 
The introduction of continuous automated monitoring gave the automated blood culture 
system a significant advantage where the instruments could serve as incubators and 
continuous agitation while under interrogation of growth independent of a technician. The 
systems reduced handling time, decreased risk for cross contamination and monitored for 
microbial growth every 10-25 minutes providing opportunity for early detection of growth. 
The first automated blood culture system that provided continuous monitoring for growth 
and was Food and Drug Administration (FDA) approved was the BacT/Alert (Organon 
Teknika, Turnhout, Belgium) system10. The BacT/Alert system utilized a sensor internally 
attached to the bottom of the blood culture bottles. The sensor was separated from the culture 
broth by a membrane permeable only to CO2. Like the previously described methods, the 
microbial metabolism increased the CO2 production. The CO2 diffused over the membrane 
to the sensor causing acidification. The acidification caused a color change to the sensor that 
was monitored every 10 minutes by light-emitting diodes light on the sensor while 
photodiodes measure the amount of red light reflected from the sensor. The red light reflected 
was proportioned to the color sensor and correlates with the CO2 production (Figure 2). The 
BacT/Alert system then applied an algorithm to differentiate positive culture bottles from 






Figure 2. Automated blood culture system monitoring of growth of microorganisms based 
on the CO2 production. 
 
 
Becton Dickinson Diagnostic Instruments Systems received FDA approval for the BACTEC 
automated and continuous monitoring blood culture in 1992. The BACTEC system uses 
fluorescence to detect CO2 production changing the membranes instead of the colorimetric 
method7. Extra Sensing Power was the third continuous monitoring method to receive FDA 
approval monitored for growth by manometric monitoring gas production or consumption by 
monitoring for pressure changes in the headspace of each bottle. Algorithms were applied to 
the pressure changes that were monitored to determine for positivity. There are additional 
automated continuously monitored blood culture systems beyond the scope of this thesis. 
However, the main blood culture systems in use are the BacT/Alert and the BACTEC system 








1. Organism metabolic activity in the bottle releases CO2
2. CO2 reacts with the dye in the sensor
3. Sensor exposed to light intermittently  
4. Photo detector reads light emitted from the sensor 
5. Analysis for positivity performed on the light emitted from the sensor 








In modern clinical microbiological laboratories, automated blood culture systems are the gold 
standard for detection of bacteria and fungi in blood as well as other normally sterile body 
fluids. Blood culture systems as well as the blood culture bottles and supplement to the blood 
culture bottles have been extensively studied11–16. The first two FDA approved automated 
blood culture systems BacT/Alert (bioMérieux) and BACTEC (Becton Dickinson) are the 
most widely used in clinical microbiology laboratories worldwide. BioMérieux introduced 
Virtuo, a new version blood culture system, to the market with automatic loading and 
unloading, improved detection algorithm and improved temperature stability compared with 
the BacT/Alert 3D (BioMérieux) system that was in use from the same company. The Virtuo 
system was evaluated in this thesis in direct comparison with the BacT/Alert 3D system. At 
the Karolinska University laboratory, more than 200 000 blood culture bottles are analyzed 
yearly, hence the new Virtuo system had the additional advantage of automatic loading and 
unloading that would free the technician to do less mechanic work and allow them to focus 
on diagnostic work. Study 1 is the first evaluation of the new automated blood culture system 




1.2.2 Identification of microorganisms 
 
Following detecting growth in the blood culture bottles, the clinical microbiology laboratory 
will focus on identifying the microorganisms. Current identification methods have been 
developed over many decades and will reliably deliver accurate pathogen identification to 
support the clinicians in guiding antimicrobial therapy. The identification of microorganisms 
is based on the morphology under microscopic evaluation, Gram stain, biochemical and 
growth characteristics of the microorganisms. The traditional approach to pathogen 
identification from positive blood culture bottles at clinical laboratories starts with the Gram 
stain and microscopic examination of the blood culture broth to examine the Gram stain and 
pathogen morphology. The Gram stain and morphology will then guide subsequent steps of 
subculture on relevant agar plates and incubation atmosphere for subculture. Bacterial 
colonies are collected after 24-72-hour subculture and further analyzed with matrix-
associated laser desorption ionization-time-of-flight mass spectrometer (MALDI-TOF MS) 
(Bruker Daltonik) or the Vitek 2 XL (BioMérieux). MALDI-TOF is a mass 
spectrophotometry system that performs protein analysis of microorganisms for 
identification as further described below.  
 
The Vitek 2 XL is a biochemical identification and AST instrument that uses instrument 
specific cards for microorganism identification and AST. The activity of the bacteria 
including growth, inhibition of growth, enzymatic activity, acidification, alkalization is used 
for automated identification and antibiotic susceptibility testing. Each well in the card is 
monitored by an optical system using different wave lengths every 15 minutes generating 
raw data. The raw data is then analyzed through a software to match for identification and 
susceptibility testing. The Vitek 2 XL system uses specific test kits including Gram-negative 
bacillus, Gram-positive cocci, Gram-negative antibiotic susceptibility and Gram-negative 










When the criteria for species identification is not met upon analyzing by the MALDI-TOF 
MS and/or Vitek 2 XL, identification is performed with additional testing. These may be 
include morphological testing (repeat Gram stain, growth on specific agar), enzymatic tests 
(catalase, oxidase, indole spot, DNase and	 L-pyrrolidonyl-b-naphthylamide) (Remel), 
agglutination tests (Streptococcus pneumonia and Group A-D and G streptococci) (Oxoid) 
and susceptibility testing (optochin discs on gentian violet blood agar plates are used). Where 
it is clinically warranted, more advanced techniques may be performed including 16S rRNA 
gene sequencing. However, despite providing reliable pathogen identification and AST, 
current culture and identification methods continue to be time consuming, taking 6-72 hours 
to identify the microorganisms after blood culture positivity. The delay in detection and 
identification of the pathogens has forced the clinical management of sepsis to use empiric 
broad spectrum antibiotic therapy pending pathogen identification18. Similar guidelines are 
available for neonatal sepsis19, meningitis3 and peritonitis20. The microbiological laboratories 
are now presented with the challenge to provide earlier reliable pathogen identification and 
AST to aid in the goal of limiting the use of empiric broad spectrum antimicrobials, thereby 
allowing targeted antimicrobial therapy earlier in the disease course. The studies included in 
this thesis explored direct identification of microbes from positive blood culture bottles using 
short-term subculture methods, as well as subculture-independent methods. 
 
MALDI-TOF MS has been described as ‘revolutionary’ and creating a ‘paradigm shift’ in 
clinical microbiology for well-deserved reasons21. The method was historically used for 
protein analysis in both research and in clinical chemistry laboratories for diagnostic 
purposes. The method was adapted to microbiological analysis and is currently at the center 
of the workflow at most major clinical microbiology laboratories for pathogen identification. 
Microorganism analysis is performed by applying sample colonies to the MALDI-TOF MS 
sample plate from solid culture media and overlay the sample with the MALDI-TOF MS 
matrix. The plate with the sample is allowed to dry before it is bombarded by the laser system 
resulting in ionization of the sample proteins and the matrix generating ions. The time-of-
flight tube will then allow separation of the ions based on their mass-to-charge. The ions are 
detected by the MS detector and generate a profile that can be used for spectra analysis and 
analyzed in the software database for microorganism identification (Figure 3)21. The entire 









Figure 3. MALDI-TOF MS method for microorganism analysis. Target plate with sample 
and matrix is bombarded by the laser causing ionization of the proteins in the sample. 
Acceleration of the ionized proteins occurs in the electrostatic field. The time of flight tube 
allows separation based on the size of the proteins since all proteins have the same charge. 
A detector picks up the ions as they reach the detector. The software matches the detection 
of the ionized proteins with an internal pattern recognition for microorganism identification.   
 
 
The MALDI-TOF MS became a central diagnostic tool due to the low cost per specimen 
analysis, the simplicity of using it and the speed in obtaining reliable identification results. 
The MALDI-TOF MS has been further evaluated for rapid identification of pathogens 
directly from positive blood cultures without first sub-culturing the culture broth on solid 
media 22,23. The protocols of rapid identification of pathogens directly from blood culture 
bottles is an additional process that may be challenging to integrate into routine diagnostic 
without significantly consuming dedicated technician time. Interestingly, a novel 
identification method was published by Özenci et al., in 2008 based on simple routine 
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The introduction of MALDI-TOF MS in the laboratory provided the opportunity to apply the 
MALDI-TOF MS to the novel method presented by Özenci et al., that was already part of 
the diagnostic process in the laboratory. The study included in the thesis (Study 2) 
investigated the performance of MALDI-TOF MS in identification of microorganisms after 
short-term subculture on solid media. The approach would have the potential to identify the 
microorganism within 2.5 h or 5.5 hours after blood culture positivity, significantly earlier 




Figure 4. The workflow for traditional- and the short-term culture steps and MALDI-TOF 
MS analysis. After blood culture positivity, subculture was analyzed with MALDI-TOF MS 
at 2.5 h, 5.5 h and 24-48 h.  
 
 
The subculture-independent methods for pathogen identification are characterized through 
the process of identification microorganisms directly from the blood culture bottles without 
the need for subculture to solid media with the aim to decrease the turnaround time for 
pathogen identification. There are currently several different subculture independent methods 
on the market. These methods may be based on MALDI-TOF MS, polymerase chain reaction 
(PCR), fluorescent nucleic acid probes, 16S rRNA and antigen/antibody-based methods25. 
The two approaches that were investigated in this thesis were the PCR-based method and the 












The PCR-based methods have dramatically improved over the years with increasing 
simplicity and a decreased cost per analysis. The FilmArray blood culture identification 
(BCID) (BioFire, Salt Lake City, UT) panel studied in this thesis (Study 3 and 4) represents 
an excellent example of these advances. The FilmArray is multiplex PCR-based platform that 
uses high-order multiplex PCR analysis in a ‘Lab-in-Pouch’ approach to identify 
microorganisms and antibiotic susceptibility genes ( Figure 5)26–28. The ‘Lab-in-pouch’ 
method uses a pouch containing the reagents required for sample preparation, PCR reactions, 
negative/positive control as well as endpoint detection with two-stage nested PCR27. In 
addition to microorganism identification, the method included AST genes as well as the 
ability to identify multiple microorganisms in the same sample in the setting of a 
polymicrobial infection. The simplicity and rapid turnaround time of one hour had the 
potential to decrease the time required by the technician to do the analysis as well decreasing 
the turnaround time. The FilmArray BCID panel was used in two studies to compare the 
methods performance with current standard diagnostic methods used for microorganism 




Figure 5. Outline the FilmArray pouch, reactions and the instrument. (Figure modified from 









Targeted single pathogen identification methods are often developed due to the high detection 
frequency of specific pathogens in specific cultures. S. pneumoniae is a good example of 
pathogens that are commonly encountered in several different cultures including SBF. S. 
pneumoniae has a unique feature of producing a cell wall enzyme in the stationary growth 
phase that causes autolysis of the microorganism in the blood culture bottle. Depending on 
the extent of the autolysis it may prevent S. pneumoniae from growing on subculture, hence 
preventing final identification and AST29. Such pathogens provide additional challenges in 
identification as it is diagnostically difficult to differentiating S. pneumoniae from other 
viridians group streptococci as they share phenotypical and genotypical features30. 
Furthermore, at the time of the study, the MALDI-TOF MS system had made extensive gain 
in the diagnostic approach to most pathogens but did not reliably distinguish the viridians 
streptococci from the S. pneumoniae due to the similarities in the protein structures of the 
organisms23. Rapid and reliable methods to identify the S. pneumoniae continue to be in 
demand despite the availability of the MALDI-TOF MS system. In the fifth and final study 
5, the performance of the ImmuLexTM S. pneumoniae Omni (Statens Serum Institut, 
Denmark) latex agglutination test was compared with the three other tests that included 
Slidex® pneumo-Kit (bioMérieux, France), the Wellcogen™ S. pneumoniae (Remel, UK) 
and the BinaxNOW (Alere, USA) in the detection of S. pneumoniae antigen directly from 
positive blood culture bottles. The simplicity of the methods provided an opportunity to 
rapidly identify microorganisms with cost effective and user-friendly agglutination tests.   
 
 13 
2 AIM OF THE THESIS 
 
The aim of this doctoral project was to improve the microbiological diagnosis of infections 
in normally sterile body fluid specimens including blood when utilizing blood culture bottles 
for pathogen detection.    
 
The specific aim(s) for each study:  
 
2.1 STUDY 1: 
To evaluate the performance of new BacT/Alert Virtuo (bioMérieux) blood culture system 
for detection and time to detection of bacteria and yeasts utilizing simulated blood cultures.     
 
2.2 STUDY 2: 
To analyze the performance of short-term culture followed by MALDI-TOF MS (Bruker) in 
rapid identification of bacteria from positive blood cultures.  
 
2.3 STUDY 3: 
To assess the performance of the FilmArray BCID (Biofire) in identification of bacteria and 
yeasts from positive blood culture bottles. 
 
2.4 STUDY 4: 
To evaluate the FilmArray BCID panel (Biofire) in identification of bacteria and yeasts in 
SBF cultured in blood culture bottles.   
 
2.5 STUDY 5:  
To compare ImmuLexTM S. pneumoniae Omni (Statens Serum Institut), Slidex® pneumo-Kit 
(bioMérieux), the Wellcogen™ S. pneumoniae (Remel) latex agglutination test and the 






3 MATERIALS AND METHODS 
 
All studies were performed at the clinical microbiology laboratory at Karolinska University 
Hospital, Huddinge, Sweden. The microbiology laboratory serves the three tertiary-care 
hospitals: Karolinska University Hospital in Huddinge, Södertälje Hospital in Södertälje and 
South General Hospital in Stockholm serving a total of 1569 beds that include both adult and 
pediatric beds.  
 
3.1 BLOOD CULTURE SYSTEMS  
 
The blood culture systems used in each study are outlined in Table 1. The blood culture 
systems include BacT/Alert 3D (bioMérieux, Marcy l'Etoile, France), BacT/Alert Virtuo 
(bioMérieux, Marcy l'Etoile, France) and Becton Dickinson (BD) BACTEC (Becton 
Dickinson Instrument Systems, Sparks, MD, USA). BacT/Alert 3D was the main blood 
culture system used for the clinical specimens during the duration of the thesis period and 
was included in all studies. BacT/Alert Virto was only utilized in the first study because the 
system was in the process of validation and clinical evaluation. BD BACTEC blood culture 
system was only used for the BD Mycosis (Becton Dickinson) blood cultures to evaluate for 
yeast infections in the clinical routine analysis at the laboratory for the purpose of evaluating 
for fungemia.  
 
Table 1. Outline of blood culture systems used each study including in the thesis. 
Study BacT/Alert 3D BacT/Alert Virtuo BD BACTEC 
1 √ √   
2 √     
3 √   √ 
4 √     







3.2 BLOOD CULTURE BOTTLES 
The blood culture bottles used in the studies dependent on both instrument limitations and 
specific clinical utilization. The blood culture bottles used in each study are outlined in Table 
2. The first study compared BacT/Alert 3D (bioMérieux, Marcy l'Etoile, France), BacT/Alert 
Virtuo (bioMérieux, Marcy l'Etoile, France) using aerobic (FA Plus) and anaerobic (FN Plus) 
BacT/Alert blood culture bottles (bioMérieux, Marcy l'Etoile, France). The second study 
included all blood cultures used for diagnostic purposes at the three tertiary hospitals. These 
additional blood culture bottles were FA charcoal, FN charcoal and the pediatric blood 
culture bottle (PF) Plus (bioMérieux, Marcy l'Etoile, France). Charcoal blood culture bottles 
were not approved to be used on the FilmArray blood culture identification panel (BCID) 
(BioFire, Salt Lake City, UT, USA) and were therefore excluded from the third and fourth 
study. The fourth study excluded the use of charcoal bottles as well as BD Mycosis (Becton 
Dickinson Instrument Systems, Sparks, MD) because they were not utilized to diagnose 
infections of sterile body fluids. Finally, the fifth study excluded the BD Mycosis blood 
culture bottles that contain antibiotics to prevent bacterial growth and are not used to detect 
bacteremia including Streptococcus pneumoniae.     
 













1 √    
2 √ √ √  
3 √  √ √ 
4 √  √  
5 √ √ √  
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3.3 SIMULATED BLOOD CULTURES 
 
Simulate blood cultures were only used in Study 1 to compare the two blood culture systems 
BacT/Alert 3D (bioMérieux, Marcy l'Etoile, France), BacT/Alert Virtuo (bioMérieux, Marcy 
l'Etoile, France). In total, 115 frozen clinical bacterial and fungal isolates were used in the 
study. Originally, the isolates were collected from clinical blood cultures that had been 
processed in the routine microbiological analysis for clinical diagnostics at Karolinska 
University Laboratory and stored in a frozen stock. Isolates were recovered from frozen 
stocks by culture on appropriate agar for 24 h (aerobe bacteria) or 48 h (anaerobe bacteria) 
in a temperature of 36°C. The bacteria were then suspended in phosphate-buffer saline 
solution (pH 7.3-7.4) to a McFarland of 0.5 (1.5 ´ 108 CFU/ml) to allow approximately 15 
colony-forming-units (CFU) to be inoculated in the blood culture bottles. The suspension 
was sub-cultured on agar to assess the CFU for control of the final inoculum. Each blood 
culture bottle was inoculated with eight milliliter defibrinated horse blood. Finally, blood 
cultures were incubated in the blood culture system until positivity or for a maximum of five 
days. Blood culture that were negative until final incubation day were sub-cultured on agar 
for control of growth.  
 
3.4 CLINICAL CULTURES  
 
The clinical blood cultures and cultures of sterile body fluids were obtained from specimens 
that were sent to Karolinska University Laboratory for clinical diagnostic purpose.  Clinical 
blood cultures were collected and inoculated by standard collection method to avoid 
contamination. Blood cultures were incubated in the BacT/Alert 3D blood culture system 
until positivity for a maximum of five days. The number of positive blood cultures included 
in Study 2 was 579, Study 3 was 206, and Study 5 was 375. Study 4 included 116 sterile body 
fluid specimens cultured using blood culture bottles. Becton Dickinson (BD) Mycosis 
(Becton Dickinson) blood culture bottles were similarly inoculated with blood and incubated 
in BD BACTEC (Becton Dickinson) until positivity or for a max incubation of 14 days. 
Briefly, 8-10 ml blood or sterile body fluid specimen were inoculated into BacT/Alert FA, 
FA Plus, FN and FN plus blood culture bottles (bioMérieux, Marcy l'Etoile, France). The PF 
bottles (bioMérieux, Marcy l'Etoile, France) were inoculated with 0.5-4 ml blood or other 
SBF. The blood culture bottles with blood were placed in the blood culture system upon 
arrival to the laboratory within normal working hours. The blood culture bottles with SBF 
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were placed in the blood culture system after inoculation of the SBF in blood culture bottles 
the laboratory.  
 
3.5 THE FILMARRAY BLOOD CULTURE IDENTIFICATION ASSAY  
 
The FilmArray blood culture identification (BCID) assay (BioFire, Salt Lake City, UT, USA) 
is an integrated reverse-transcription-PCR that utilizes a pouch to dry store all necessary 
reagents for sample preparation, reverse-transcription-PCR, PCR and for detection of 
bacterial and fungal pathogens. The FilmArray BCID panel includes 19 bacteria, five 
Candida species and three antimicrobial gene targets (Table 3). 
 
FilmArray analysis was performed by inserting one milliliter hydration buffer into the pouch 
using the accompanied product syringe and hydration buffer. Then, 100 μl blood culture 
bottle broth (with blood or sterile body fluid) was diluted in 500 μl accompanied FilmArray 
dilution buffer. Finally, 300 μl of the diluted sample was injected in the FilmArray pouch 
before loading the pouch in the FilmArray system for analysis. FilmArray automatically 
performed the DNA extraction, amplification, melt curve analysis, two internal control (for 
primary amplification and the analyze-specific detection stages) and target detection within 
60 minutes. The automated system only provided results if the internal quality controls were 




Table 3. The microorganisms and antimicrobial resistance genes included in the FilmArray 
BCID Panel. 
 
Reference: Altun O, Almuhayawai M, Ullberg M, Ozenci V. Clinical evaluation of the FilmArray blood culture 




by both FilmArray and conventional methods. Only one blood culture per
patient was used in the prospective evaluation of the FA BCID panel.
Conventional microbiological methods. Gram stains were done di-
rectly from positive blood culture bottles. According to the results of the
staining, specimens from the positive bottles were subcultured onto rele-
vant agar plates. The microorganisms grown on the agar plates were iden-
tified by Bruker MALDI-TOF MS (Bruker Daltonics, Bremen, Germany),
by Vitek2 XL (bioMérieux, Marcy l’Etoile, France), and by a panel of
validated desktop spot tests, including catalase, oxidase, indole spot, and
L-pyrrolidonyl-!-naphthylamide (Remel Inc., Lenexa, KN) tests and ag-
glutination tests for Staphylococcus aureus (Staphaurex latex test; Remel
Europe Ltd., Dartford, United Kingdom), group A, B, C, D, and G strep-
tococci, Streptococcus pneumoniae (Oxoid, Basingstoke, United King-
dom), and Salmonella sp. (Reagensia, Stockholm, Sweden). The suscepti-
bility testing was performed by disc diffusion according to the EUCAST
method. In three cases of discordant mecA results between FA and disc
diffusion, conventional mecA PCR was performed.
FilmArray BCID. The FilmArray BCID panel received a Conformité
Européenne In Vitro Diagnostics (CE IVD) marking in June 2013, autho-
rizing it to be used in Europe for the purpose of in vitro diagnostic exam-
ination. The panel includes 19 bacteria, five yeasts, and three antibiotic
resistance genes: mecA, vanA/vanB, and the KPC gene (Table 1). Briefly, it
is a closed diagnostic system that combines nucleic acid extraction from
clinical specimens, high-order nested multiplex PCR, and post-PCR DNA
melting curve analysis. When the blood culture bottle yielded a positive
signal in the blood culture system, 100 "l of broth from the positive
culture was diluted in 500 "l sample dilution buffer, and then 300 "l of
this sample solution was injected into the FA pouch for analysis. Extrac-
tion, amplification, detection, and analyses were completely automated
within the pouch. Results of the assay were provided by the software only
if the quality control reactions were appropriately detected. Each pouch
includes two internal run controls for both the primary amplification and
the analyte-specific detection stages. When either of the two control fails,
the result is listed as “invalid.”
Reproducibility tests. Five positive blood cultures, one of each with S.
aureus, methicillin-resistant Staphylococcus aureus (MRSA), coagulase-
negative staphylococci (CoNS), Escherichia coli plus alpha-hemolytic
streptococci, and Escherichia coli plus Klebsiella pneumoniae, were tested
with the FilmArray twice during the same day.
Longitudinal follow up with FilmArray. In order to evaluate the per-
formance of FilmArray in positive blood cultures that had been stored at
room temperature (RT) over a longer period, five blood culture bottles
growing S. aureus, CoNS with mecA, E. coli, Klebsiella oxytoca, and Can-
dida glabrata were tested with FilmArray repeatedly in the 3 to 4 weeks
following blood culture positivity (day 1). The blood culture bottles were
taken out of the blood culture system when they yielded a positive signal
and stored at RT during this period.
Statistical analysis. The detection rates of FilmArray and conven-
tional microbiological methods were compared using Fisher’s exact test.
RESULTS
In total, 206 blood culture bottles were included in the study.
There were 167 and 24 positive blood cultures with mono- and
polymicrobial growth, respectively. For 12 samples, Gram stain-
ing and cultures were negative despite the fact that bottles yielded
a positive signal in the blood culture system. In 3/206 (1.5%) bot-
tles, the FilmArray results were invalid. The longitudinal perfor-
mance of the FA was evaluated in five positive blood cultures by a
total of 29 tests during a period of 4 weeks. For another five sam-
ples, the FA results were repeated twice in the same day in order to
evaluate the reproducibility of the method. During the study pe-
riod, 236 FilmArray tests were performed and three were invalid,
giving a 1.3% pouch failure rate.
Diversity of the clinical isolates. Thirty-five different species
were isolated during the study period. The FilmArray BCID panel
covered 24/35 (69%) isolates. The three Enterococcus spp., Entero-
coccus faecalis, E. faecium, and E. avium, were identified at the
genus level by FilmArray. Interestingly, 175/191 blood culture
bottles with positive growth had microorganisms that were in-
cluded in the FilmArray BCID panel, covering 91.6% of the clin-
ical isolates during the study period.
Monomicrobial growth. The FilmArray identified 153/167
(91.6%) samples with monomicrobial growth. Thirteen of the 167
(7.8%) microorganisms were not included in the FilmArray BCID
panel and could not be identified (Table 2). These were three
Micrococcus spp., two Corynebacterium spp., two Peptoniphilus
spp., and one of each Gemella sp., Bacteroides fragilis, Capnocy-
tophaga canimorsus, Eggerthella lenta, Parvimonas micra, and Lac-
tobacillus sp. Interestingly, only 1/167 (0.6%) microorganisms,
i.e., one coagulase-negative staphylococcus (CoNS), that was in-
cluded in the FA BCID panel and positive in blood culture could
not be detected by FilmArray. In contrast, in 6/167 (3.6%) sam-
ples, FilmArray detected an additional microorganism compared
to blood culture. In four blood culture bottles with CoNS and in
one bottle with S. pneumoniae, FilmArray simultaneously de-
tected Enterococcus spp. In another blood culture bottle with C.
glabrata, FilmArray detected also Candida albicans (Table 2).
Polymicrobial growth. When polymicrobial growth was ana-
lyzed, both FilmArray and blood cultures could detect all micro-
organisms in 17/24 (71%) samples (Table 3). In 6/24 (25%) poly-
microbial cultures, FilmArray could not detect one or more of the


























Antibiotic resistance markers mecA
vanA/vanB
KPC
a In total, the panel includes 27 targets, namely, 11 Gram-negative and 8 Gram-positive
bacteria, 5 Candida spp., and 3 antibiotic resistance markers.
Evaluation of the FilmArray ID Panel
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3.6 MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT 
MASS SPECTROMETRY (MALDI-TOF MS)   
 
MALDI-TOF MS (Bruker Daltonik, Hamburg, Germany) analysis was performed directly 
on bacteria grown on agar plates. In brief, a thin layer from bacterial colonies grown on agar 
plates was scraped using a one milliliter bacterial loop and smeared on a spot on the 96-spot 
stainless steel target plate (Bruker Daltonik, Hamburg, Germany). Protein extraction was 
performed on the plate using 70% formic acid solution (Fluka) and allowing the sample to 
dry for two minutes.  One microliter alpha-cyano-4-hydroxycunnamic acid (CHCA matrix) 
(Bruker Daltonik) was then applied on the sample and dried before analyzing it with the 
MALDI-TOF MS system (Bruker Daltonik). Spectra analysis was performed using Bruker 
Biotype 3.1 software and library (version 4613, Bruker Daltonik). Score cut offs for 
identification were used according to the MALDI-TOF MS manufacturers guidelines. Scores 
>1.7 were interpreted as low-confidence identification but considered as successful 
identification if confirmed by conventional methods obtained overnight. A Score of <1.7 was 
considered failed identification.  
 
3.7 STREPTOCOCCUS PNEUMONIAE ANTIGEN TESTS  
 
In study 5, the performance of four S. Pneumoniae antigen tests was evaluated. These tests 
were ImmuLexTM S. pneumoniae Omni (Statens Serum Institut, Denmark) LA, SlideX® 
pneumo-Kit (bioMérieux, Marcy l'Etoile, France), WellcogenTM S. pneumoniae (Remel, UK) 
LA and BinaxNOW® S. pneumoniae (Abbot, USA).  The tests were done according to the 
manufacturer’s instructions. Briefly, the ImmuLexTM test was performed by mixing one drop 
of the blood culture drop with one drop of the anti-S. Pneumoniae latex suspension on the 
reaction card. A positive result was obtained if agglutination was observed within five 
minutes. The ImmuLexTM had a negative control using one drop from the negative control 
bottle with one drop of the latex suspension. The Slidex® test was performed by centrifuging 
one milliliter blood culture broth at 2000 rpm for 10 minutes and using one drop of the 
supernatant to mix with one drop of anti-S. pneumoniae latex suspension on a glass slide for 
two minutes or until agglutination was observed. The negative control for the Slidex® tests 
was done by applying one drop of the supernatant on a glass slide and mixing it with the 
accompanied control latex suspension. The WellcogenTM test was performed by mixing one 
milliliter drop of the anti-S. pneumoniae latex suspension on the reaction card. The negative 
control was done by mixing one drop of the blood culture broth with one drop of accompanied 
control latex. The specimens were mixed on the card for two minutes or until agglutination 
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was observed. For all tests, the presence of agglutination in the tests and the absence of 
agglutination in the negative control was considered a positive test while agglutination in the 
negative control was considered an unreliable for identification (invalid test result). An 
invalid test was repeated at least once. The BinaxNOW® was performed by applying one 
drop from the positive blood culture broth and visually reading the membrane for positive 
and control line after 15 minutes. The presence of a positive line on the testing card and the 
absence of the negative control line was interpreted as a positive test.   
  
3.8 CONVENTIONAL METHODS FOR IDENTIFICATION OF 
MICROORGANISMS   
 
The conventional methods for identification of microorganisms from positive blood culture 
bottles were utilized in the laboratory for routine clinical diagnostic purposes. Positive blood 
cultures broth was first analyzed by Gram-stain. The broth was subsequently cultured on agar 
plates based on the Gram-stain and incubated for 24-48 hours. Identification of 
microorganisms was done by analyzing growth on agar plates with MALDI-TOF MS (Bruker 
Daltonic) or Vitek2 XL (bioMérieux, Marcy l'Etoile, France). Validated desk spot tests, 
agglutination tests, ozidase, indole spot and L-pyrrolidonyl-β-naphthylamide as indicated. 
Discrepant results were further analyzed with subcultures, selective media and repeat 
MALTI-TOF MS and/or Vitek2 XL analysis. Susceptibility testing was performed with the 
disc diffusion method in accordance with the EUCAST guidelines (http://www.eucast.org). 
Staphylococcus spp. were tested for methicillin resistance with the cefoxitin disc diffusion 
method. Klebsiella pneumoniae carbapenems testing was with the imipenem and meropenem 
disc diffusion method.  
 
In study 5, amplification and sequencing of 16S rRNA and/or recA was utilized according to 








3.9 PROTOCOL DESCRIPTION FOR EACH STUDY 
3.9.1 Study 1: Controlled evaluation of the new BacT/Alert Virtuo blood 
culture system for detection and time to detection of bacteria and 
yeast   
 
The performance of detection and time of detection of the new BacT/Alert Virtuo 
(bioMérieux, Marcy l'Etoile, France) blood culture system was compared with the 
BacT/Alert 3D (bioMérieux, Marcy l'Etoile, France) blood culture system by parallel 
incubation of 115 clinical bacterial and fungal isolates. Isolates were recovered from frozen 
stock of isolates that were collected from positive clinical blood cultures at the Karolinska 
University Laboratory. The isolates were suspended and inoculated in aerobic (FA and FA 
Plus (bioMérieux, Marcy l'Etoile, France)) and anaerobic (FN and FN Plus (bioMérieux, 
Marcy l'Etoile, France)) blood culture bottles to simulated blood cultures and use them to 
compare the performance of the two blood culture systems in detection and time to detection 
(Figure 6). The aerobic microorganisms Candida spp. and Acinetobacter spp. were only 
cultured in aerobic blood cultures. The CE-approved version of the BacT/Alert Virtuo system 
was intended to operate on the new resin-based blood culture bottles (FA Plus and FN Plus). 
The charcoal-based blood culture bottles (FA and FN) were included in the investigational-
use-only version of the Virtuo employed in this study. Blood cultures were sub-cultured at 
the end of the incubation period to exclude contamination and confirm true positive/negative 
results.   
 
 
Figure 6. Outlines protocol for study 1. Bacteria from frozen stock sub-cultured, then 
resuspended. Each blood culture bottle was inoculated with the resuspended bacteria. The 
resuspension was cultured for control. All positive and negative blood cultures were sub-















3.9.2 Study 2. Rapid identification of bacteria from positive blood culture 
bottles by MALDI-TOF MS following short-term incubation on solid 
media. 
 
The performance of MALDI-TOF MS (Bruker Daltonik, Hamburg, Germany) in identifying 
microorganisms from blood culture bottles after a short-term incubation on solid media was 
evaluated in comparison with conventional culture and identification methods. The MALDI-
TOF MS analysis was performed after 2.5- and 5.5 h incubation time of positive blood culture 
broth cultured on solid media. Positive blood cultures were sub-cultured on blood/CLED and 
chocolate agar in 5% CO2 atmosphere. When microorganisms were suspected to be 
anaerobes by Gram stain and morphological evaluation, the sub-culture was done on blood 
agar plates and incubated in 35°C in anaerobic environment. The MALDI-TOF MS 
microorganism identification results after short-term incubation was compared with 
conventional culture and identification methods.   
 
3.9.3 Study 3. Clinical evaluation of the FilmArray BCID in identification of 
bacteria and yeast from positive blood culture bottles. 
 
This prospective clinical study was performed to evaluate the performance of the new 
FilmArray BCID panel. The study included only one blood culture per patient and the results 
of the FilmArray BCID panel were compared with conventional culture and identification as 
well as AST.  
 
3.9.4 Study 4. Rapid identification of microorganisms from sterile body 
fluids by use of FilmArray BCID 
 
This prospective clinical study evaluated the performance of the FilmArray BCID in 
identifying microorganisms in positive blood culture bottles inoculated with sterile body fluid 
for bacterial and yeast analysis. Reproducibility testing as well as longitudinal testing of the 






3.9.5 Study 5. Rapid identification of Streptococcus pneumoniae in blood 
cultures by using the ImmuLexTM, Slidex® and WellcogenTM latex 
agglutination tests and the BinaxNOW® antigen test.  
 
The performance of the new latex agglutination test ImmuLexTM S. pneumoniae Omni was 
compared with Slidex® pneumo-Kit, WellcogenTM S. pneumoniae and BinaxNOW® S. 
pneumoniae antigen test in detecting S. pneumoniae in positive blood cultures. This was a 
prospective clinical study where blood culture bottles with growth for gram positive cocci in 




3.10 STATISTICAL ANALYSIS FOR EACH STUDY 
 
In Study 1, GraphPad Prism 6 was used to perform the statistical analysis. The time to 
detection (TTD) between the two blood culture systems were compared using the 2-way 
matched analysis of variance (ANOVA) or Wilcoxon matched-pair signed-rank test. The 
Mann-Whitney U test was used to compare TTD between the groups of microorganisms. The 
Spearman correlation was used to assess TTD values by each of the two blood culture 
systems. The p-value of <0.05 was used to measure the statistical difference.  
 
In Study 2, statistical analysis was not performed as the purpose of the study was not directed 
at finding a statistical difference between the MALDI-TOF MS short term incubation and the 
conventional method. Fisher’s exact test may be used to compare the two diagnostic methods. 
However, the rapid test is a complement to the conventional diagnostic methods and a direct 
percent comparison is sufficient for clinical comparing the diagnostic utility of the rapid test.   
 
In Study 3, Fisher’s exact test was used to compare the identification performance of the 
FilmArray BICD with the conventional culture and identification methods.  
 
In Study 4, a statistical analysis was not applied due to the limited number of each organism 
detected in the study. Overall statistical analysis would not be clinically valuable for the same 
reason.  
 
In Study 5, McNamara’s test for paired samples was used to compare the proportions. A 





3.11 ETHICAL PERMISSION   
 
Ethical permission was not required for the present five studies. In accordance with the 
Swedish ethical law for research in human subjects or biological material derived from 
human subjects, the specimens were coded and cannot be traced back to the humans that 
provided the specimens. The biological material was collected for the diagnostic purposes 
for clinical management. No additional clinical sample was collected from patients. The 
human subjects were therefore not exposed to a physical procedure to collect specimens for 
the studies in the thesis. The study results were not used during the study period to direct 




4.1 MICROORGANISMS  
 
The studies included a total of 1387 isolates, which constituted of 374 Gram-negative (Table 
4), 964 Gram-positive (Table 5), and 49 yeast (Table 6) isolates. Table 4, 5 and 6 outlines the 
number of each Gram negative, Gram positive and yeast isolates respectively in each study. 
Study 2 excluded cultures with yeasts because of their slow growth. Study 5 did not include 









Organism Total Study 1 Study 2 Study 3 Study 4 Study 5
Escherichia coli 190 10 129 39 12
Enterobacter asburiae 2 2
Enterobacter aerogenes 4 3 1
Enterobacter cloacae 6 2 2 1 1
Enterobacter kobei 8 8
Klebsiella pneumoniae 50 7 29 9 4 1
Klebsiella oxytoca 19 3 10 3 3
Raoultella planticola 1 1
Citrobacter freundii 7 6 1
Citrobacter koseri 2 2
Citrobacter farmeri 1 1
Morganella morganii 1 1
Proteus vulgaris 1 1
Proteus mirabilis 10 8 2
Salmonella  spp. 6 4 2
Serratia marcescens 18 12 4 2
Nisseria meningitidis 1 1
Aeromonas  spp. 2 1 1
Acinetobacter spp. 7 7  
Acinetobacter ursingii 1 1
Pseudomonas aeruginosa 12 2 4 5 1
Brucella  spp. 1 1
Haemophilus influenzae 6 1 2 1 2
Bacteroides fragilis 9 7 2
Bacteroides vulgatus 1 1
Bacteroides thetaiotaomicron 1 1
Parabacteroides distasonis 1 1
Prevotella  spp. 3 1 2
Veillonella parvula 1 1
Fusobacterium necrophorum 1 1
Anaerobic rodd non-speciated 1 1
Total 374 39 229 69 32 5
No. of Gram-negative Isolates in Each Study
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Organism Total Study 1 Study 2 Study 3 Study 4 Study 5
Staphylococcus aureus 130 10 61 22 35 2
Staphylococcus capitis 13 12 1
Staphylococcus epidermidis 88 84 4
Staphylococcus haemolyticus 2 2
Staphylococcus hominis 29 29
Staphylococcus pettenkoferi 2 2
Staphylococcus saprophyticus 1 1
Coagulase negative staphylococcus non-speciated 66 5 2 44 14 1
Enterococcus faecalis 43 5 28 10
Enterococcus faecium 18 5 7 6
Enterococcus casseliflavus 1 1
Enterococcus spp. 53 21 9 23
Streptococcus agalactiae (Group B streptococci) 13 5 5 3
Streptococcus dysgalactiae (Group G streptococci) 4 2 2
Streptococcus pyogenes (Group A Streptocci) 11 3 3 3 1 1
Streptococcus anginosus 7 4 2 1
Streptococcus gallolyticus 2 2
Streptococcus parasanguinis 3 2 1
Streptococcus pneumoniae 306 13 8 14 5 266
Streptococcus salivarius 2 2
Alpha-streptococci spp. 102 6 9 11 9 67
Streptococcus spp. 6 6
Gemella sanguinis 2 1 1
Rothia mucilaginosa 1 1
Micrococcus spp. 10 3 4 3
Listeria monocytogenes 5 2 2 1
Bacillus thuringiensis 1 1
Corynebacterium spp. 7 2 2 3
Lactobacillus spp. 16 15 1
Pediococcus acidilactici 1 1
Clostridium halophilum 1 1
Clostridium perfringens 2 1 1
Clostridium spp. 1 1
Propionibacterium acnes 4 3 1
Propionibacterium avidum 1 1
Eggerthella lentad 2 1 1
Gram-positive anaerobic rod unspeciated 2 2
Peptoniphilus spp. 2 2
Parvimonas spp. 1 1
Bacillus spp. 2 1 1
Actinomyces spp. 1 1
Total 964 49 286 151 116 362
No. of Gram-positive Isolates in Each Study
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Table 6. The yeasts included in the thesis. 
 
*Study two and study five did not include any yeast pathogens. 
 
 
4.2 EVALUATION OF BACT/ALERT VIRTUO BLOOD CULTURE SYSTEM. 
 
In Study 1, in total, 115 clinical isolates (Figure 7) were used to inoculate a total of 392 
blood culture bottle pairs (total 784 blood culture bottles) to compare the BacT/Alert Virtuo 
with the BacT/Alert 3D blood culture system. The majority (760/784 (97%)) signaled 
positive within the five-day incubation period. The number of negative blood culture bottle 
was 24 (12 bottles in each blood culture system) with no difference of negative blood culture 
bottle in each system. The negative blood cultures were inoculated with Acinetobacter spp. 
(n=1 pair), coagulase-negative staphylococci (CoNS) (n=3 pairs), alpha-hemolytic 
streptococci (n=7 pairs), one alpha-hemolytic streptococcus isolate that grew in the Virtuo 
and one Acinetobacter spp. that grew only in BacT/Alert 3D blood culture system. Subculture 
of the negative blood cultures confirmed the absence of growth and confirmed true negative 
culture.  
 
Organism Total Study 1 Study 2* Study 3 Study 4 Study 5*
Candida albicans 25 12 7 6
Candida glabrata 22 15 4 3
Candida crusei 1 1
Candida parapsilosis 0
Saccharomyces cerevisiae 1 1
Total 49 27 0 11 11 0




Figure 7. Outline of the clinical isolates used in Study 1. 
 
In comparing the time to detection (TTD) among the 379 blood culture bottle pairs that 
signaled positive in the two systems, the TTD was significantly shorter in the Virtuo blood 
culture system then BacT/Alert 3D (median TTD 12 h and 15 hours respectively; P<0.0001) 
which is a 20% reduction in TTD. Further stratification of the positive blood culture pairs 
showed that 90% of the positive blood culture bottles were positive in 16 h in the Virtuo 
compared with 21 h in the BacT/Alert 3D system. There was no difference among bacterial 
species or type of blood culture bottle used. The blood culture bottles inoculated with 
Candida spp. signaled positive within three days (71 h) in the Virtuo compared with four 




























4.3 RAPID IDENTIFICATION BY MATRIX-ASSOCIATED LASER DESORPTION 
IONIZATION-TIME OF FLIGHT MASS SPECTROMETER (MALDI-TOF MS) 
AFTER SUBCULTURE ON SOLID MEDIA  
 
In study 2, a total of 579 positive blood cultures were studied. For the study, 12 (12/579, 
2.1%) blood cultures were excluded due to polymicrobial growth and 52 (52/579, 9%) due 
to growth of yeast. The remaining 515 blood cultures were 286 (55.5 %) Gram-positive 
bacteria (GPB) and bottles and 229 (44.5 %) Gram-negative bacteria (GNB) (Figure 8). 
Conventional methods identified 267/286 (93.4 %) GPB and 223/229 (97.4 %) GNB to the 
species level after overnight culture. Accurate identification of by MALDI-TOF MS after 2.5 




Figure 8. Overview of MALDI-TOF MS identification of Gram-negative and Gram-positive 








Identification at 2.5 h 
(n=120 (42%))






Identification at 2.5 h 
(n=180 (78.6%))








As outlined in Figure 8, there is a marked difference in the identification of GNB compared 
with GPB after 2.5 h subculture,180/229 (78.6 %) and 120/286 (42.0 %), respectively. 
Further studying the specific pathogens in the GNB (Table 8) and GPB (Table 7) reveals that 
the majority of Enterobacteriaceae and S. aureus were identified in 2.5 h, 173/209 (82.8 %) 
and 44/61 (72.1 %), respectively.  
 
With the additional 90 GBP and 34 GNB identified after 5.5 h culture on solid media, a total 
of 424/515 (82.3 %) of all isolates included in the study were identified generating a 
cumulative identification rate of 73.4 % for GPB and 93.4 % for GNB at this time point. 
Further analysis of Table 7 reveals that most of the S. aureus (56/61, 91.8 %), Enterococci 
spp. (33/36, 91.7 %) and beta-haemolytic streptococci group A, B and G (8/10, 80 %) were 
correctly identified at the end (5.5 h) of the short-term culture period. In contrast, Major 
limitations were seen in the identification of Streptococcus pneumoniae (2/8), other alpha-
hemolytic streptococci (3/19) and anaerobic GPB (2/10).  
 
Table 8 presents the identification results of GNB including the identification of 9/14 



















Table 7. Gram-positive bacteria identified during the study period in Study 2. 
 
Reference: Altun O, Botero-Kleiven S, Carlsson S, Ullberg M, Özenci V. Rapid identification of bacteria from positive 
blood culture bottles by MALDI-TOF MS following short-term incubation on solid media. Journal of Medical 
Microbiology. 2015, 00, 1-7. PMID: 263 
 
 
After 5.5 h. Identification of an additional 90 GPB and
34 GNB could be achieved by the presented method
after 5.5 h growth on agar plates. In total, 424/515
(82.3 %) of all isolates included in the study were
identified at this time point; the cumulative rates of
identification after 5.5 h being 73.4 % for GPB and
93.4 % for GNB.
The majority of Staphylococcus aureus (56/61, 91.8 %),
enterococci (33/36, 91.7 %) and b-haemolytic streptococci
group A, B and G (8/10, 80 %) were correctly identified
at the end of the short-term culture period. Identification
of non- Staphylococcus aureus staphylococci was less success-
ful as only 101/132 (76.5 %) of the isolates could be charac-
terized to the species level. Major limitations were seen in
Table 1. Identification of GPB by rapid culture followed by MALDI-TOF MS and by conventional methods
CoNS, Coagulase-negative staphylococci.
Organism Rapid culture followed by MALDI-TOF Conventional methods
2.5 h 5.5 h No ID .24 h
Staphylococcus spp. 96 (49.7 %) 61 (31.6 %) 36 (18.7 %) 193 (100 %)
Staphylococcus aureus 44 12 5 61
Staphylococcus capitis 7 3 2 12
Staphylococcus epidermidis 30 30 24 84
Staphylococcus haemolyticus 1 1 0 2
Staphylococcus hominis 13 13 3 29
Staphylococcus pettenkoferi 1 1 0 2
Staphylococcus saprophyticus 0 1 0 1
Other CoNS* 0 0 2 2
Enterococcus spp. 16 (44.4 %) 17 (47.3 %) 3 (8.3 %) 36 (100 %)
Enterococcus faecalis 14 12 2 28
Enterococcus faecium 1 5 1 7
Enterococcus casseliflavus 1 0 0 1
Streptococcus spp. 5 (13.5 %) 8 (21.6 %) 24 (64.9 %) 37 (100 %)
Streptococcus agalactiae 3 2 0 5
Streptococcus dysgalactiae 0 0 2 2
Streptococcus pyogenes 1 2 0 3
Streptococcus anginosus 0 0 4 4
Streptococcus gallolyticus 0 0 2 2
Streptococcus parasanguinis 1 0 1 2
Streptococcus pneumoniae 0 2 6 8
Streptococcus salivarius 0 2 0 2
Other a-streptococciD 0 0 9 9
Other GPB 3 2 5 10
Gemella sanguinis 1 0 0 1
Rothia mucilaginosa 0 1 0 1
Micrococcus spp. 0 0 3 3
Listeria monocytogenes 2 0 0 2
Bacillus thuringiensis 0 1 0 1
Corynebacterium spp. 0 0 2 2
Anaerobic GPB 0 2 8 10
Clostridium halophilum 0 1 0 1
Clostridium perfringens 0 1 0 1
Clostridium spp. 0 0 1 1
Propionibacterium acnes 0 0 3 3
Propionibacterium avidum 0 0 1 1
Eggerthella lentad 0 0 1 1
Gram-positive anaerobic rod 0 0 2 2
Total 120 (42 %) 90 (31.5 %) 76 (26.5 %) 286 (100 %)
*Could not be identified by MALDI-TOF MS or Vitek 2; both isolates were DNase negative.
DThese isolates could not be identified by MALDI-TOF MS; they were classified as a-streptococci based on optochin resistance and negative aggluti-
nation for group A, B, C, D, G streptococci and Streptococcus pneumoniae. Vitek 2 was not performed in these cases.
dIdentified by Vitek 2, with a high identification score of 99 %.
Rapid culture and MALDI-TOF MS
http://jmm.microbiologyresearch.org 3
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Table 8. Gram-negative bacteria identified during the study period in Study 2.  
 
Reference; Altun O, Botero-Kleiven S, Carlsson S, Ullberg M, Özenci V. Rapid identification of bacteria from positive 
blood culture bottles by MALDI-TOF MS following short-term incubation on solid media. Journal of Medical 






the identification of Streptococcus pneumoniae (2/8), other
a-haemolytic streptococci (3/19) and anaerobic GPB (2/10).
When aerobic GNB bacteria were considered, the additional
culture time further raised the identification rate for Enter-
obacteriaceae from 173/209 (82.8 %) to 201/209 (96.2 %)
correctly identified species, and for non-Enterobacteriaceae
to 4/6 isolates (66.8 %). Interestingly, 9/14 anaerobic GNB
could be identified successfully after 5.5 h. In particular,
the method performed unexpectedly well for Bacteroides
spp., identifying 8/9 of the isolates.
Isolates that could not be identified by this approach.
Most of the remaining bacteria were represented by too
few isolates to evaluate the performance of the method.
Gram-positive rods such as Corynebacterium spp. or
Propionibacterium spp. and anaerobes other than Bacteroides
spp. were difficult to identify after rapid culture (Tables 1
and 2). Similarly, 24/37 (64.9 %) Streptococcus spp. could
not be identified correctly. In general, these micro-
organisms either showed no growth after rapid culture or
did not yield a reliable identification result, i.e. scores v1.7
with MALDI-TOF MS. False species identification was only
observed in the case of 4 a-haemolytic streptococci that
were incorrectly typed as Streptococcus pneumoniae (data not
shown). These isolates were identified (to the species or
genus level) by standard microbiological identification tests,
including MALDI-TOF MS from overnight cultures.
DISCUSSION
Hitherto published studies have shown that early effective
antimicrobial treatment of patients with BSI is crucial in
Table 2. Identification of GNB by rapid culture followed by MALDI-TOF MS and by conventional methods
Organism Rapid culture followed by MALDI-TOF Conventional methods
2.5 h 5.5 h No ID .24 h
Enterobacteriaceae 173 (82.8 %) 28 (13.4 %) 8 (3.8 %) 209 (100 %)
Escherichia coli 107 17 5 129
Enterobacter asburiae 2 0 0 2
Enterobacter aerogenes 3 0 0 3
Enterobacter cloacae 2 0 0 2
Enterobacter kobei 8 0 0 8
Klebsiella pneumoniae 25 4 0 29
Klebsiella oxytoca 6 2 2 10
Raoultella planticola 1 0 0 1
Citrobacter freundii 4 1 1 6
Citrobacter koseri 2 0 0 2
Morganella morganii 1 0 0 1
Proteus mirabilis 5 3 0 8
Salmonella spp.* 3 1 0 4
Serratia marcescens 4 0 0 4
Other GNB 3 1 2 6
Aeromonas hydrophila 1 0 0 1
Acinetobacter ursingii 1 0 0 1
Pseudomonas aeruginosa 1 1 0 2
Brucella spp.D 0 0 1 1
Haemophilus influenzae 0 0 1 1
Anaerobic GNB 4 5 5 14
Bacteroides fragilis 2 4 1 7
Bacteroides vulgatus 1 0 0 1
Bacteroides thetaiotaomicron 0 1 0 1
Parabacteroides distasonis 1 0 0 1
Prevotella oralis 0 0 1 1
Veillonella parvula 0 0 1 1
Fusobacterium necrophorum 0 0 1 1
Gram-negative anaerobic rodd 0 0 1 1
Total 180 (78.6 %) 34 (14.8 %) 15 (6.6 %) 229 (100 %)
*As all Salmonella spp. were identified only at the genus level by conventional methods at $24 h, MALDI-TOF MS identification at the genus level
was accepted as a successful identification.
DFor biosafety reasons, the isolate was sent for typing by PCR to a reference laboratory.
dCould not be identified by MALDI-TOF MS or Vitek 2 because of insufficient bacterial growth even after .24 h.
O. Altun and others
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4.4 RAPID PATHOGEN IDENTIFICATION BY FILMARRAY BCID PANEL 
DIRECTLY FROM BLOOD CULTURE BOTTLES  
 
The study included a total of 206 positive blood cultures, including 167 (Table 9) and 24 
(Table 10) positive blood cultures with mono- and polymicrobial growth respectively and 12 
blood cultures that signaled positive but were negative on Gram stain and subculture. 
Longitudinal performance was assessed by repeatedly analyzing the same five positive blood 
cultures over four weeks by a total of 29 tests. Reproducibility was assessed by running 
another set of five positive blood cultures twice during the same day. During the study period, 
236 FilmArray tests were performed with 3/236 (1.3%) pouch failures encountered 
secondary to negative/positive control in the pouch.   
 
Thirty-five different species were identified by conventional identification methods from the 
included specimens. The FilmArray BCID panel included targets to detect 24/35 (69%) of 
the isolates (Enterococcus spp. were identified on the genus level). The FilmArray BCID 
panel identified 153/167 (91.6%) pathogens in the monomicrobial growth blood cultures 
(Table 9). Among the monomicrobial growth blood cultures there was 13/167 (7.8%) 
microorganisms that were not included in the FilmArray BCID panel including three 
Micrococcus spp., two of each Corynebacterium spp., and Peptoniphilus spp., and one of 
each Parvimonas micra, Bacteroides fragilis, Eggerthella lenta, Capnocytophaga 
canimorsus, Gemella spp., and Lactobacillus spp. There was 1/167 (0.6%) false negative 
result and included a CoNS. The FilmArray detected an additional microorganism in 6/167 
(3.6%) samples. These six specimens included four blood culture bottles with CoNS, one 
with S. pneumoniae with FilmArray simultaneously detected Enterococcus spp., and in one 
with C. glabrata where FilmArray detected also C. albicans. In five specimens, FilmArray 






Tabell 9. Identification of bacteria, yeast and antimicrobial resistance genes from the 167 
blood culture bottles with monomicrobial growth included in Study 3. 
 
Reference; Altun O, Almuhayawai M, Ullberg M, Ozenci V. Clinical evaluation of the FilmArray blood culture identification 
panel in identification of bacteria and yeasts from positive blood culture bottles. Journal of Clinical Microbiology. 
2013;51(12):41 
 
In blood cultures with polymicrobial growth, the FilmArray BCID accurately detected all 
microorganisms in 17/24 (71%) cultures (Table 10). FilmArray did not detect one or more 
organisms in 6/24 (25%) blood cultures with polymicrobial growth. The microorganisms that 
were not detected in 4/6 of these blood cultures were not included in the panel leaving 2/6 as 
failure to identify the microorganism  
microorganisms detected by blood cultures. In two samples, one
with E. faecalis plus Streptococcus pyogenes and one with E. faecalis
plus CoNS, FilmArray failed to detect E. faecalis. In two other
polymicrobial samples, one with E. coli plus Bacteroides fragilis
and one with Propionibacterium acnes plus Micrococcus sp.,
FilmArray could detect none of the four microorganisms. It is
important to ote that 3/4 microorganisms in these two amples
were not included in the FilmArray BCID panel. In one sample
with S. pneumo iae plus CoNS plus Bacillus sp., FilmArray could
not detect the Bacillus sp., which is not in the FilmArray BCID
panel. In another sample with K. pneumoniae plus Clostridium
perfringens plus alpha-hemolytic streptococci, FilmArray could
not identify C. perfringens plus alpha-hemolytic streptococci; C.
perfringens is not in the FilmArray BCID panel (Table 3). In con-
trast, in one blood culture bottle with CoNS plus alpha-hemolytic
streptococci, FilmArray additionally detected Enterococcus spp.
mecA, vanA/vanB, and blaKPC. In total, there were 67 mecA
results in the FilmArray analysis. In th 57 monomicrobial sam-
ples with Staphylococcus spp., one MRSA isolate, 18 methicillin-
susceptible S. aureus (MSSA) isolates, 16 methicillin-susceptible
CoNS, and 14 methicillin-resistant CoNS were detected both by
FilmArray and blood cultures. Interestingly, three CoNS that were























Coagulase-negative staphylococci 37 1
Staphylococcus aureus 19
Streptococcus pneumoniae 13






Candida albicans 6 1
Candida glabrata 4











mecA 15b 1 3c
vanA/vanB 0 0
a Six E. faecalis and 3 E. faecium isolates.
b One MRSA isolate and 14 methicillin-resistant CoNS.
c PCR showed that 1/3 CoNS was mecA positive, as shown by FilmArray, whereas 2/3 were mecA negative, as in the disc diffusion test.
Altun et al.
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Table 10. Identification of bacteria, yeasts and detection of antibiotic resistance markers in 
24 polymicrobial blood cultures by FilmArray BCID panel in Study 3. 
 
Reference; Altun O, Almuhayawai M, Ullberg M, Ozenci V. Clinical evaluation of the FilmArray blood culture 




methicillin susceptible according to the disc diffusion method
were identified as mecA positive in the FilmArray. In order to
evaluate the mecA result, conventional mecA PCR was performed.
The PCR result showed that 1/3 CoNS were mecA positive, as
determined by the FilmArray, whereas 2/3 were mecA negative, as
determined by disc diffusion. The only CoNS that could not be
detected by the FilmArray was methicillin resistant.
Ten polymicrobial samples, including at least one Staphylococ-
cus sp., were also analyzed for mecA by FilmArray. In 5/5 samples
that were methicillin resistant according to the disc diffusion
method, FilmArray could detect mecA. In 4/5 methicillin-suscep-
tible staphylococci, the FilmArray result were also mecA negative.
In one sample with S. aureus plus CoNS, the FilmArray detected
mecA without being able to distinguish MRSA or MSSA in the
sample. Subsequent phenotypical tests later determined that the S.
aureus isolate was MSSA and the CoNS was methicillin resistant.
None of the 24 Enterococcus spp. detected by the FilmArray was
positive for vanA or vanB, which was in concordance with the 19
culture-positive enterococci that were susceptible to vancomycin
by the disc diffusion method.
No microorganism was carbapenem resistant or blaKPC posi-
tive during the study period.
Overall performance of FilmArray. Table 4 shows the true-
and false-positive and -negative results, sensitivities, specificities,
and negative and positive predictive values for each microorgan-
ism included in the FA BCID panel.
FilmArray identified all microorganisms in 170/175 (97.1%)
blood cultures positive for microorganisms that were included in
the FA BCID panel. There was no statistical difference between
FilmArray and conventional blood culture for detection of micro-
organisms that are in the panel. When all blood culture bottles
were considered, FilmArray was able to identify all microorgan-
isms in 170/191 (89.5%) blood culture bottles included in the
study. Conventional cultures had a higher detection rate than
FilmArray (P ! 0.001).
Twelve blood culture bottles that yielded a positive signal in the
blood culture system but showed no growth were also negative by
FilmArray.
Time to detection. In total, the mean (standard deviation
[SD]) time to detection (TTD) for positive blood cultures was
21.67 (18.56) h. The blood cultures that were positive for micro-
organisms not included in the FA BCID panel had a longer mean
(SD) TTD, 53.92 (23.30) h. The blood culture bottle with CoNS
that could not be detected by FilmArray yielded a positive signal
after 42 h.
Reproducibility tests. There was no difference between the
two FilmArray results for each of the five blood culture bottles
tested during the same day, suggesting that the FA method is re-
producible (data not shown).
When longitudinal follow-up of positive blood cultures was
considered, the FilmArray was positive for the correct pathogen at
all time points, i.e., for S. aureus, E. coli, and CoNS (with mecA) on
days 1, 7, 14, 21, and 28 and for C. glabrata and K. oxytoca on days
1, 2, 3, 4, 11, 17, and 21 (data not shown).
Blood culture bottle type. In the monomicrobial group, 82
BacT/Alert FA Plus, 71 BacT/Alert FN Plus, five Bactec Mycosis
IC/F, and nine BacT/Alert PF Plus blood culture bottles were in-
cluded. The performance of the FilmArray was equally good in all
four blood culture bottle types tested. No FilmArray detection was
observed in nine BacT/Alert FA Plus and three BacT/Alert FN Plus
blood culture bottles that were false positive; i.e., these bottles
yielded a positive signal in the absence of growth. In 3/9 BacT/
Alert PF Plus and 1/82 BacT/Alert FA bottles, FilmArray detected
one Enterococcus sp. that was not detected by blood cultures. In
contrast FilmArray failed to detect CoNS in 1/82 BacT/Alert FA
Plus bottle that yielded a positive blood culture.
Ten BacT/Alert FA Plus bottles, 13 BacT/Alert FN Plus bottles,
and one BacT/Alert PF Plus bottle were positive for multiple or-
ganisms. In 1/12 BacT/Alert FA bottles, FilmArray detected one
Enterococcus sp. that was not detected by blood cultures. In 2/10
BacT/Alert FA, 3/13 BacT/Alert FN, and 1/1 BacT/Alert PF Plus
bottles, FilmArray failed to detect one or more microorganisms
that were detected by blood culture.
DISCUSSION
With extensive advances in instrumentation, clinical microbiol-
ogy laboratories can dramatically improve sensitivity, specificity,
and turnaround times in the diagnosis of invasive infections (13,
14). The aim of the present study was to evaluate one of the re-
cently developed rapid methods in this field, the use of the Film-
Array BCID panel.
The FilmArray BCID panel includes a limited number of
TABLE 3 Direct identification of bacteria and yeasts and detection of







Enterococcus faecium, CoNS 1, 1 1, 1
Escherichia coli, Klebsiella pneumonia 1, 1 1, 1
Candida albicans, Enterococcus faecalis 1, 1 1, 1
Enterobacter cloacae, Enterococcus faecium 1, 1 1, 1
Enterococcus faecalis, Pseudomonas aeruginosa 1, 1 1, 1
Enterococcus faecium, alpha-hemolytic streptococci 1, 1 1, 1
Enterococcus faecium, CoNS 1, 1 1, 1
Escherichia coli, alpha-hemolytic streptococci 1, 1 1, 1
Escherichia coli, Klebsiella pneumoniae 1, 1 1, 1
Escherichia coli, alpha-hemolytic streptococci 1, 1 1, 1
Klebsiella oxytoca, Enterococcus faecium 1, 1 1, 1
Serratia sp., alpha-hemolytic streptococci 1, 1 1, 1
Staphylococcus aureus, CoNS 1, 1 1, 1
Staphylococcus aureus, alpha-hemolytic streptococci 1, 1 1, 1
Staphylococcus aureus, Pseudomonas aeruginosa 1, 1 1, 1
CoNS, alpha-hemolytic streptococci 1, 1 1, 1
Streptococcus pyogenes, Enterococcus faecalis 1, 1 1, 0
CoNS, Enterococcus faecalis 1, 1 1, 0
Escherichia coli, Bacteroides fragilis 1, 1 0, X
Propionibacterium acnes, Micrococcus sp. 1, 1 X, X
Escherichia coli, Klebsiella pneumoniae, Enterococcus
avium
1, 1, 1 1, 1, 1
CoNS, alpha-hemolytic streptococci, Enterococcus 1, 1, 0 1, 1, 1
Klebsiella pneumoniae, Clostridium perfringens,
alpha-hemolytic streptococci
1, 1, 1 1, X, 0




a 1, detection of a microorganism or antibiotic resistance marker in the BCID panel; 0,
failure to detect; X, the microorganism was not included in the panel.
Evaluation of the FilmArray ID Panel
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The antibiotic resistance marker mecA, vanA/vanB and blaKPC was simultaneously tested in 
all microorganisms. The FilmArray analysis revealed a total of 22 mecA (17 in the 
monomicrobial- and five in the polymicrobial samples, respectively).  
 
In the monomicrobial specimens, three coagulase-negative staphylococcus that were 
methicillin sensitive with the disc diffusion method were identified as mecA positive with the 
FilmArray. Conventional mecA PCR showed that 1/3 CoNS was true mecA positive, while 
2/3 were mecA negative, as determined by disc diffusion. In addition, the only CoNS that 
could not be detected in the study by the FilmArray was methicillin resistant. 
 
In the polymicrobial specimens, all samples (5/5) that were methicillin resistant according to 
the disc diffusion method were mecA positive on the FilmArray analysis. In 4/5 methicillin-
susceptible Staphylococci, the FilmArray result were also mecA negative.  One of these 
samples contained S. aureus plus CoNS, and the FilmArray detected mecA without being 
able to distinguish if the S. aureus was a methicillin resistant S. aureus (MRSA) or if the 
CoNS was the pathogens positive for the mecA gene making the S. aureus a methicillin 
sensitive S. aureus (MSSA) in the sample. Subsequent phenotypical tests were used to 
determined that the S. aureus isolate was MSSA and the CoNS was methicillin resistant. 
 
Conventional culture and susceptibility methods and FilmArray did not identify any blaKPC 
or vanA/vanB during the study period.  
 
Overall, the FilmArray identified all microorganisms covered by the FilmArray BCID panel 




4.5 FILMARRAY MICROORGANISM IDENTIFICATION IN POSITIVE BLOOD 
CULTURES INOCULATED WITH STERILE BODY FLUID SPECIMENS 
 
Culture positive SBF specimens (n=116) from 106 patients were included in the study. The 
specimens were pleural (n=51), synovial (n=38), abscess (n=10), dialysis (n=9), 
cerebrospinal (n=7) and bile (n=1) fluid. Monomicrobial growth was identified in 92/116 
(79%) and polymicrobial growth in 24/116 (21%) (Table 11 and 12). The pouch failure rate 
was 1/116 (1%) and due to invalid internal run controls. Thirty different species were isolated 
from the specimens and 25/30 (83%) were covered by the FA BCID panel. FilmArray 
accurately identified 84/92 (91%) bottles with monomicrobial growth. Eight of the 92 (9%) 
bottles with monomicrobial growth contained microorganisms that were not included in the 
the FilmArray BCID panel.  
 
All microorganisms included in the FilmArray BCID panel were detected in 18/24 (75%) 
blood culture bottles with polymicrobial growth. There were conflicting results in the 
remaining 6/24 (25%) specimens for FilmArray and the reference method (Table 12).  
 
The results for antibiotic susceptibility testing were in concordance between the FilmArray 
and the disc diffusion method (Table 11 and 12). There were no vanA, vanB or blaKPC 


















Tabell 11. Identification of bacteria, yeast and antibiotic markers in the 92 SBF specimens 
with monomicrobial growth. 
 
Reference. Altun O, Almuhayawai M, Ullberg M, Özenci V. Rapid identification of microorganisms from sterile body fluids 
by use of FilmArray. Journal of Clinical Microbiology. 2015;53(2):710–2. PMID: 25520440Table 9. Detection rate for 






negativ due to noninclusi n on the panel. (Table 1). FilmArray
identified all microorganisms included in the FA BCID panel in
18/24 (75%) specimens with polymicrobial growth (Table 2).
These constituted 10/24 (42%) specimens where the FilmArray
results were in concordance with those of the reference method. In
3/24 (13%) specimens, FilmArray detected additional microor-
ganisms compared to the results for conventional culture meth-
ods, and these were later confirmed by additional cultures.
FilmArray could identify the microorganisms that were included
in the FA BCID panel in 5/24 (21%) specimens; however, these
specimens also included microorganisms that were not in the
panel. Conflicting results for FilmArray and the reference method
were observed in 6/24 (25%) specimens (Table 2).
The FilmArray and disc diffusion results were concordant for
the detection of seven Staphylococcus spp. with mecA. There were
no vanA- or vanB-positive Enterococcus spp. and no blaKPC-posi-
tive organisms detected during the study period.
The FilmArray accurately identified all microorganisms in-
cluded in the FA BCID panel in 84/84 (100%) mono- and 18/24
(75%) polymicrobial growths, respectively. The remaining micro-
organisms in 8/92 (9%) bottles with monomicrobial growth were
not included in the FA BCID panel (Table 1). The clinical rele-
vance of these eight microorganisms was not analyzed. However,
Micrococcus species, Corynebacterium species, and Bacillus cereus
a e usually considered contaminants, as they are part of normal
skin microbiota, while Actinomyces species and Aeromonas species
may be clinically significant findings in certain patient popula-
tions. This is a common limitation with similar rapid methods
that are directed toward identifying the most common clinically
significant microorganisms (12, 14, 15).
The identification of microorganisms from bottles with poly-
microbial growth is demanding for both conventional and rapid
identification methods (12, 14, 16). Certain specimens in this
study demonstrated that conventional identification methods
may initially fail to identify microorganisms in bottles with poly-
microbial growth. There are several reasons for this, including the
overgrowth of rapidly growing microorganisms in relation to
slow-growing organisms in the same bottles and limited selective
agar plates used in routine culture. Interestingly, the FilmArray
identified all microorganisms included in the FA BCID panel in
18/24 (75%) bottles with polymicrobial growth and affirmed our
previous results on blood cultures (13). In contrast, several rapid
methods, including MALDI-TOF MS, have performed poorly in
blood cultures with polymicrobial growth (12, 17, 18).
FilmArray could identify 3/3 and 9/9 yeasts in mono- and poly-
microbial growth, respectively. Our present results show that, in
addition to five Candida species, the FA BCID panel is capable of
simultaneous identification of bacteria and antibiotic resistance
TABLE 1 Identification of bacteria and yeasts and detection of antibiotic resistance markers from 92 monomicrobial SBF cultures by FilmArray and
reference method
Identification







Microorganism or marker included in FA BCID panel
Gram-positive bacteria
Staphylococcus aureus 32
Coagulase-negative staphylococcus 13 1a
Streptococcus pneumoniae 3
Enterococcus spp. 7












Antibiotic resistance marker mecA 2






a The FilmArray identified Staphylococcus spp., while the reference method as well as additional culturing identified B. cereus.
b The FilmArray identified Enterococcus spp. and Streptococcus spp., while the reference method and additional cultures only identified Enterococcus faecalis.
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Tabell 12. The bacteria, yeast and antibiotic markers detected in the 24 specimens with 
polymicrobial growth. 
 
Reference: Altun O, Almuhayawai M, Ullberg M, Özenci V. Rapid identification of microorganisms from sterile body fluids 
by use of FilmArray. Journal of Clinical Microbiology. 2015;53(2):710–2. PMID: 25520440 
 
 
genes. This is a distinct advantage of the FA BCID panel over many
other rapid methods, including Yeast Traffic Light PNA FISH
(fluorescence in situ hybridization using peptide nucleic acid
probes) assay. This is particularly important when the treatment
of polymicrobial infections in SBF is challenging due to the pres-
ence of multiple microorganisms with different susceptibility pro-
files against antimicrobial agents.
In conclusion, this study demonstrates that the FA BCID pro-
vides reliable, prompt results from positive blood culture bottles
with SBF. Larger clinical studies, preferably in combination with
antibiotic stewardship programs, are warranted to assess the im-
pact of the FA BCID on hospital costs and patient outcome.
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TABLE 2 Results for polymicrobial specimens analyzed by the
FilmArray and reference method
Specimen
(n ! 24)
Microorganisms identified by FilmArray and the reference
methodsa
Pleural fluid Enterococcus faecalis, E. coli, P. aeruginosa
Pleural fluid E. faecalis, P. aeruginosa, C. albicans, coagulase-negative
staphylococcus, Foxrb
Pleural fluid E. coli, Staphylococcus epidermidis, Foxr
Pleural fluid Enterococcus avium, E. coli
CSF S. epidermidis, Foxs, E. coli
Pleural fluid E. faecalis, P. aeruginosa
Pleural fluid Enterococcus faecium, Citrobacter farmeri, S.
epidermidis, Foxr
Pleural fluid E. faecium, E. faecalis, E. coli, C. albicans
Pleural fluid E. faecalis, E. faecium, S. aureus
Pleural fluid E. faecalis, E. faecium, C. albicans
Pleural fluid E. faecalis (Staphylococcus capitis, Foxr)
Pleural fluid E. faecalis, Proteus vulgaris, Citrobacter freundii
(S. aureus)
Abscess E. faecium, E. coli (K. pneumoniae)
CSF E. coli, Micrococcus spp.
Bile E. faecalis, Enterobacter cloacae, Klebsiella oxytoca,
Prevotella spp.
Pleural fluid E. faecium, alpha-hemolytic streptococcus, Candida
krusei, Candida parapsilosis, Saccharomyces cerevisiae
Pleural fluid S. pneumoniae, Prevotella spp.
Pleural fluid C. glabrata, Pediococcus acidilactici, Lactobacillus spp.
Pleural fluid C. glabrata, C. albicans, S. epidermidis, Foxr, E. faecium,
(Streptococcus salivarius)
Abscess E. faecalis, E. avium, E. coli, K. oxytoca, anaerobic flora
(Enterococcus spp., E. coli, K. oxytoca, Streptococcus oralis,
P. aeruginosa, H. influenzaec)
Abscess E. coli (Streptococcus anginosus, K. oxytoca)
Pleural fluid C. albicans (S. pneumoniaec; culture broth was Wellcogen
positive)
Pleural fluid Alpha-hemolytic streptococcus, E. faecalis (no growth on
culture)
Pleural fluid S. aureus (S. anginosusd)
a The reference methods were conventional culture methods. Boldface shows names or
markers identified by both FilmArray and the reference method, lightface shows
identification only by the reference method, underlined names were not included in the
FA BCID panel, and names or markers in parentheses were identified first only by FA
BCID and were later confirmed by the reference method after additional subcultures of
the bottle culture broth.
b FilmArray detected mecA, while conventional methods used the disc diffusion
method. Foxr, cefoxitin resistant; Foxs, cefoxitin susceptible.
c We were unable to confirm H. influenzae and S. pneumoniae on repeated cultures.
d On repeated culturing, S. anginosus was found instead of the Enterococcus spp. on
FilmArray analyses.
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4.6 RAPID IDENTIFICATION OF STREPTOCOCCUS PNEUMONIAE IN 
POSITIVE BLOOD CULTURES WITH ANTIGEN TESTS 
 
The study included 373 (358 BC bottles with Gram-positive cocci in pairs or chains and 15 
bottles negative by Gram stain) blood cultures from 159 patients. S. pneumoniae was 
identified by conventional culture methods in 266/358 (74.3 %) bottles and 92/358 (25.7 %) 
bottles were positive for non-pneumococcal pathogens. These were α-haemolytic 
streptococci (n = 67) and other species, Enterococcus spp., (n=23), Klebsiella pneumoniae 
(n =1) and Enterobacter cloacae (n=1). To differentiate between the α-hemolytic streptococci 
sequencing of 16S rRNA and/or recA genes was performed in 53/67 (79.1 %) isolates. The 
15 negative blood cultures included in the study were 12/15 (80%) companion bottles from 
patients with at least one bottle positive for S. pneumoniae. Three bottles were collected from 
patients with only negative bottles.  
 
Sensitivity analysis (Table 13) revealed similar sensitivity of 99.6–100% in all tests after 
excluding invalid results in the calculation. When including invalid tests in the performance 
analysis, the positivity rates of the Slidex and Wellcogen tests were 86.5 % (CI, 81.8–90.1 
%) and 92.5 % (CI, 88.7–95.1 %), respectively. The sensitivity was significantly lower than 
the ImmueLex 99.6% (CI, 97.9-99.9) and the BinaxNow 100% (CI, 98.6–100) (p < 0.01).  
 
The specificity (Table 14) calculation utilized the non-pneumococcal pathogens in the 
assessment. The ImmuLex was significantly less specific than the Slidex test (82.6% vs 
97.6%, p<0.01), and similar to the Wellcogen test (84.5%, p=ns). In comparison, the 
ImmuLex was more specific than the BinaxNOW test (64.1%, p<0.01). The BinaxNow had 
the lowest specificity (64.1%, p<0.01). A positive test result was seen when analyzing alpha-
hemolytic streptococci with BinaxNow in 25/67 (37.3%), ImmuLex in 12/67(17.9%), 




Table 13. Sensitivity of the four tests in Study 5.  
 
Reference; Altun O, Athlin S, Almuhayawai M, Strålin K, Özenci V. Rapid identification of Streptococcus pneumoniae in 
blood cultures by using the ImmuLex, Slidex and Wellcogen latex agglutination tests and the BinaxNOW antigen test. 
European Journal of Clinical Microbiology & Infectious Diseases. 2016;35(4): 579–85. PMID: 26796552 
 
2 min and no agglutination was observed on the control slide.
No agglutination on either slide was recorded as a negative
result. If agglutination appeared on the control slide, the test
was considered invalid.
To perform theWellcogen test, 1–2ml of positive BC broth
was mixed with one drop of anti-S. pneumoniae latex suspen-
sion in one circle on the reaction card. In another circle, one
drop of supernatant was mixed with one drop of control latex.
The card was rotated for a maximum of 2 min while any
agglutination was observed. A positive result was recorded
when agglutination was observed in the test circle within
3 min and no agglutination was observed in the control circle.
No agglutination in either circle was recorded as a negative
result. If a positive reaction appeared in the control circle, the
test was considered invalid.
All LA tests were read visually under normal light condi-
tions. Positive and negative controls for each LA test were
performed according to the manufacturer’s instructions. Any
invalid test was re-analysed by a second laboratory technician.
The BinaxNOW test was performed on BC broth as rec-
ommended by the manufacturer for usage on urine specimens.
Briefly, the BC broth was sampled with the sample swab,
whereafter the swab was inserted into the test device. The test
results were recorded by visual reading after 15 min. Avisible
test line of any intensity was considered a positive test result.
Statistical methods
McNemar’s test for paired samples was used for the
comparison of proportions. A confidence interval (CI)
of 95 % was used for statistical precision. A two-tailed
p-value of < 0.01 was considered statistically significant
to adjust for multiple comparisons. To evaluate the con-
tribution of invalid test results, a sensitivity analysis of
the study results was performed, by calculating the sen-
sitivity and specificity with and without invalid test
results included. The statistical analyses were performed
with a statistical software package (GraphPad Prism 6).
Results
A total of 373 BC bottles obtained from 159 patients were
included in the study. Of these, 358 BC bottles were positive
for Gram-positive cocci in pairs or chains and 15 bottles were
negative by Gram stain. Based on standard microbiological
methods, 266/358 (74.3 %) bottles were positive for
S. pneumoniae and 92/358 (25.7 %) bottles were positive for
non-pneumococcal pathogens, including !-haemolytic strep-
tococci (n=67) ± other species,Enterococcus species (n=23),
Enterobacter cloacae (n = 1) and Klebsiella pneumoniae
(n=1); see Table 2. A total of 53/67 (79.1 %) !-haemolytic
streptococci isolates were analysed by sequencing of
16S rRNA and/or recA genes in order to differentiate
between species. Of 15 negative BC bottles, 12 were
identified as companion bottles collected from patients
with another bottle positive for S. pneumoniae and three
bottles were collected from patients with only negative
bottles. Of the 373 included BC bottles, the ImmuLex
test was valid in all cases (n= 373; 100 %), in compar-
ison with the Slidex (n= 330; 88.5 %; p< 0.001) and
Wellcogen (n= 351; 94.1 %; p< 0.001) tests (Tables 1
and 2). Only valid test results were included in the
performance analyses of the four tests.
The three LA tests and the BinaxNOW test showed similar
sensitivities, ranging from 99.6 to 100 % on BC bottles pos-
itive for S. pneumoniae, with negative test results in only two
cases (Table 1). One bottle was negative only with the
ImmuLex and Wellcogen tests and one bottle was negative
only with the Slidex test. The BinaxNOW test was positive
on all BC bottles. If invalid test results were included in the
performance analysis, the positivity rates of the Slidex and
Wellcogen tests yielded 86.5 % (CI, 81.8–90.1 %) and
Table 1 Sensitivity of the
ImmuLex LA test in comparison
with the Slidex and Wellcogen
LA tests and with the BinaxNOW
antigen test when applied on BC
bottles (n = 266) positive for
Streptococcus pneumoniae
ImmuLex Slidex Wellcogen BinaxNOW
Positive test result, n 265 230 246 266
Negative test result, n 1 1 1 0
Invalid test result, n 0 35 19 0
Sensitivity, invalid results not
included, % (95 % CI)a
99.6 (97.9–99.9) 99.6 (97.6–99.9) 99.6 (97.8–99.9) 100 (98.6–100)
Sensitivity, invalid results
included, % (95 % CI)b
99.6 (97.9–99.9) 86.5 (81.8–90.1) 92.5 (88.7–95.1) 100 (98.6–100)
LA latex agglutination; BC blood culture; CI confidence interval
a Sensitivity was calculated on BC bottles positive for S. pneumoniae (n= 266) by dividing the sum of positive
test results by the number of valid results
b In a sensitivity analysis of the study result, sensitivity was calculated on BC bottles positive for S. pneumoniae
(n = 266) by dividing the sum of positive test results by the total number of results including the invalid results
Eur J Clin Microbiol Infect Dis (2016) 35:579–585 581
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Table 14. Specificity results for the four tests in Study 5.  
 
Reference: Altun O, Athlin S, Almuhayawai M, Strålin K, Özenci V. Rapid identification of Streptococcus pneumoniae in 
blood cultures by using the ImmuLex, Slidex and Wellcogen latex agglutination tests and the BinaxNOW antigen test. 
European Journal of Clinical Microbiology & Infectious Diseases. 2016;35(4): 579–85. PMID: 26796552 
 
  
92.5 % (CI, 88.7–95.1 %), respectively, which were signifi-
cantly lower than the sensitivity rates of the other twomethods
(p<0.01 for all comparisons; Table 1).
There were significant differences between the speci-
ficity rates among the four methods, calculated on BC
bottles positive for non-pneumococcal pathogens
(Table 2). The ImmuLex test was less specific than
the Slidex test (82.6 % vs. 97.6 %, p< 0.01) but per-
formed similarly to the Wellcogen test (85.4 %; p= ns).
In comparison, the ImmuLex test was more specific
Table 2 Specificity of the ImmuLex LA test in comparison with the Slidex andWellcogen LA tests andwith the BinaxNOWantigen test when applied
on BC bottles with respect to identified pathogen
n ImmuLex Slidex Wellcogen BinaxNOW
!-Haemolytic streptococcia
Streptococcus oralis 11 5 1 1 10
Streptococcus mitis 7 1 0 0 4
Streptococcus anginosus 6 0 0 1 0
Streptococcus sanguinis 5 0 1 1 1
Streptococcus tigurinus 5 2 0 3 1
Streptococcus dentisani 4 1 0 1 1
Streptococcus salivarius 3 0 0 0 0
Streptococcus gallolyticus 2 1 0 0 1
Streptococcus constellatus 1 1 0 0 0
Streptococcus intermedius 1 0 0 0 0
Streptococcus lutetiensis 1 0 0 0 1
!-Haemolytic streptococci 10 1 0 2 5
!-Haemolytic streptococcia + other species
S. mitis + CoNS 2 0 0 1 0
S. mitis + Pseudomonas aeruginosa 2 0 0 1 0
Streptococcus parasanguinis + CoNS 1 0 0 0 0
S. salivarius + Streptococcus pyogenes 1 0 0 0 0
S. sanguinis + CoNS 1 0 0 0 1
!-Haemolytic streptococci + Staphylococcus aureus 2 0 0 0 0
!-Haemolytic streptococci + Haemophilus influenzae 2 0 0 0 0
Other Gram-positive cocci
Enterococcus species 23 2 0 2 8
Gram-negative pathogensb
Enterobacter cloacae 1 1 0 0 0
Klebsiella pneumoniae 1 1 0 0 0
Total 92 16 2 13 33
Invalid test results 0 8e 3f 0
Specificity, invalid results not included, % (95 % CI)c 82.6 (73.6–89.0) 97.6 (91.7–99.4) 85.4 (76.6–91.3) 64.1 (53.9–73.2)
Specificity, invalid results included, % (95 % CI)d 82.6 (73.6–89.0) 89.1 (81.1–94.0) 82.6 (73.6–89.0) 64.1 (53.9–73.2)
LA latex agglutination; BC blood culture; CoNS coagulase-negative staphylococci; CI confidence interval
a A total of 53/67 (79.1 %) !-haemolytic streptococci isolates were analysed by sequencing of 16S rRNA and/or recA genes in order to differentiate
between species
b Identified by MALDI-TOF MS
c Specificity was calculated on BC bottles positive for non-pneumococcal pathogens (n= 92) by dividing the sum of negative test results by the number
of valid results
d In a sensitivity analysis of the study result, specificity was calculated on BC bottles positive for non-pneumococcal pathogens (n = 92) by dividing the
sum of negative test results by the total number of results including invalid results
e Eight BC bottles positive for S. mitis (n= 2), S. tigurinus (n= 2), S. oralis (n= 1), S. sanguinis (n= 1), S. dentisani (n = 1) and S. mitis + CoNS (n = 1) not
shown in the table elsewhere
f Three BC bottles positive for S. oralis (n= 1), S. anginosus (n= 1) and S. mitis (n = 1) not shown in the table elsewhere






Study utilized clinical specimens and simulated blood cultures to evaluate the two blood 
culture systems. The study showed that the overall TTD was significantly shorter by 18% for 
bottles incubated in BacT/Alert Virtuo blood culture system than in BacT/Alert 3D (median 




In Study 2, the turn-around-time for identification after subculture was the culture time (2.5 
h and 5.5 h) in addition to 30 minutes hands on time considering the time for sub-culture, and 
MALDI-TOF MS analysis.  
 
In study 3 and 4, the turn-around time for the FilmArray BCID instrument was 65 minutes 
(5 minutes hands-on followed by 60-minute system analysis).  
 








Infections of normally SBFs including blood are associated with high morbidity and 
mortality 2–4,6,19. The overall aim of this thesis was to evaluate and improve the process of 
microbiological analysis of SBF infections from blood cultures including the detection, 
identification of pathogens and antibiotic susceptibility testing. The standard of microbiology 
analysis provides the base for clinical management and has implications on mortality, 
morbidity, length of hospital stays, health care costs and the use of broad-spectrum 
antibiotics. The infections are commonly encountered in the clinical settings and demand 
early clinical detection, rapid collection of the SBF specimen for microbiological analysis 
and initiation of empiric antibiotic therapy as early as possible after clinically suspecting the 
infection.  
 
Blood cultures are a highly sensitive in detection of microorganisms causing infections of 
SBF including blood25. The automated blood culture systems have further improved the 
detection and the time to detection through continuous monitoring for growth in the blood 
culture bottles32. The most widely used blood culture systems are BacT/Alert 3D 
(bioMérieux), VersaTREK (Thermo Scientific) and the Becton Dickinson BACTEC (Becton 
Dickinson). BioMérieux introduced the new blood culture system, Virtuo, with automated 
loading and unloading of blood culture bottles in addition to a closed stable incubation 
temperature as well as a new enhanced colorimetric technology for detection of growth in 
the blood culture bottles. The established blood culture system in use at the Karolinska 
University laboratory was the BacT/Alert 3D system.  In Study 1, the Virtuo system was 
compared with the BacT/Alert 3D system in detection and time to detection by parallel 
incubation of a total of 115 clinical isolates in simulated blood cultures. Simulated blood 
cultures were used in this study to identify a difference in performance of detection and time 
to detection in the setting of ‘if all things were equal’ prior to launching a clinical study. The 
study showed that the two systems had a similar detection rate of growth suggesting that ‘if 
all things were equal’ the new blood culture system was not inferior in detecting growth in 
the blood culture bottles to the established blood culture system. However, among the 379 
bottle pairs that signaled positive in the two blood culture systems the time to detection was 
significantly shorter for bottles incubated in the Virtuo compare with the BacT/Alert 3D 
system (median 12 h and 15 h, respectively; p<0.001) without significant difference in 
bacterial species or blood culture bottle type.  
 
48 
Interestingly, the investigation showed marked differences in TTD for two Candida species, 
with 24 h for C. albicans and 66 h for C. glabrata (p <0.0001). 
 
The significance of these findings is best appreciated when taking in the context of the 
clinical practice. Overall, the TTD is closely tied with initiating and/or modifying the 
antimicrobial therapy as well as further processing for pathogen identification and 
susceptibility testing.  The shorter TTD may have major impact on samples processed during 
normal office hours where a 2-3 hours shorter TTD may be translated to Gram stain, 
identification and antibiotic susceptibility results being available 12-24-hours earlier. The 
shorter TTD seen with the yeast isolates may impact the time to appropriate antifungal 
therapy.  C. glabrata had shorter TTD by 9 hours in the Virtuo and has a different 
susceptibility to antifungal agents than C. albicans33.  
 
There are several limitations with Study 1. While the utilization of simulated blood culture 
bottles even outs the field “if all things were equal” it also cannot rule out if other factors 
clinically encountered may have an impact on the TTD. These factors include the presence 
of antibiotics, total parenteral nutrition, transport time, polymicrobial infections and other 
inhibitory or stimulatory factors may impact the TTD results. Further clinical studies are 
warranted to evaluate for the factors encountered in clinical specimens and in the processing 
of clinical specimens including transportation time.   
 
In Study 2, the MALDI-TOF MS was evaluated for rapid identification of microorganisms 
from positive blood cultures after short term sub-culture on solid media. The sub-culture of 
positive blood culture was already an integrated part of the diagnostic process in the lab 
according the to the study presented by Özenci et al., 200824. The method of short term 
subculture was therefore further explored with the application of the MALDI-TOF MS. 
MALDI-TOF MS has revolutionized the process of microorganism identification by 
decreasing the turnaround time, low cost per isolate analyzed, extensive list of organisms that 
it can identify and simple sample processing21. The study included 515 monomicrobial blood 
cultures and accurately identified 300/515 (58.3%) after 2.5 h and 424/515 (82.3%) bacteria 
after 5.5 h subculture on the solid media. The overall bacterial identification in the study 
obtained at 5.5 h are comparable to the identification rates obtained by direct MALDI-TOF 
MS seen in several studies22,34,35. Direct MALDI-TOF MS method is based on several steps 
of centrifugation to isolate the microorganisms from the blood culture bottle broth and allow 
the MALDI-TOF MS spectrum analysis.  
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The challenges with the direct MALDI-TOF MS is the obstacles to integrate it as an 
additional method alongside the standard methods for identification. In contrast, the short-
term subculture approach was modified with the addition of utilizing the MALDI-TOF MS 
rapid and cost-effective identification capabilities alongside the established conventional 
identification methods. The additional benefit of short-term subculture is the opportunity to 
initiate the antibiotic susceptibility testing as described by Idelevich et al., 2014 35. The 
shortcoming of MALDI-TOF MS in identifying S. pneumoniae from other alpha-hemolytic 
streptococci were encountered in the study as previously described36. The limitation of the 
short-term culture method was also seen in slow growing organisms such as the alpha-
hemolytic streptococci where the identification rate was poor.  
 
The results of study two showed that a user-friendly method could be utilized alongside the 
conventional identification methods to identify 82% of the bacteria in monomicrobial blood 
cultures. It may provide an addition to the opportunity to be able to initiate the antimicrobial 
susceptibility testing earlier. However, the method was limited by slow growing organisms, 
polymicrobial blood cultures and yeast organisms.  
 
In Study 3, the performance of the FilmArray BCID system was analyzed for identifying 
microorganisms directly from positive blood culture bottles. The study included 206 blood 
culture bottles and accurate identification was made in 153/167(91.6%) with monomicrobial- 
and 17/24 (71%) with polymicrobial growth and 91.6% of the microorganisms encountered 
in the study were covered in the BCID panel. The results of identification of bacteria in bottles 
with monomicrobial growth was higher when compared with the MALDI-TOF MS 
identification subsequent to short term culture on solid media. The FilmArray detected 9/9 
Candida spp. detected during the study period. However, similar results can be achieved with 
direct MALDI-TOF MS for both monomicrobial growth as well as yeast infections37–39. The 
major disadvantage to the direct MALDI TOF MS is the additional preparation steps that is 
required and hence its performance is user dependent. In contrast, the FilmArray is user-
friendly and only requires five minutes for sample preparation and initiation of analysis. The 
major advantage with the direct MALDI-TOF MS as well as performing MALDI-TOF MS 
after short-term incubation on solid media is that most major diagnostic laboratories already 
have an in-house MALDI-TOF MS. The FilmArray was clearly superior to the MALDI-TOF 
MS in detection of S. pneumonia where 14/14 were accurately detected, and that none of the 
12 alpha-streptococci were misidentified as S. pneumonia.  
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The FilmArray detected the Enterococci on species level only. This is a limitation because 
the antibiotic treatment for E. faecium and E. faecalis are different (Vancomycin and 
Ampicillin, respectively). The FilmArray stood out when looking at the performance in 
detecting all microorganism in blood cultures with polymicrobial growth with accurate 
identification of 17/24 (74%). In comparison, direct MALDI-TOF MS cannot reliably 
identify all microorganism in blood cultures with polymicrobial growth22.  
 
In Study 3, the FilmArray detected Enterococcus spp. in five specimens that were culture 
negative and thus representing false positive results. After the publication of the paper, the 
result analysis software in the FilmArray was further optimized by the manufacturer to 
mitigate false positive results. The software version used in the original paper was 1.3.0. 
When the five previous false positive samples were analyzed with the new software 1.4.1, no 
Enterococcus were detected. Thus further improved the sensitivity and specificity for 
Enteroccus in Study 3 from 88.9% and 97.3, to 88.9 and 10% respectively40.      
 
The third study was a prospective clinical study that had some limitations. The number of 
samples with less common microorganisms such as Serratia spp., and Salmonella spp., were 
limited. Similarly, there were no blaKPC or vanA/vanB detected during the study period. 
Further clinical studies are therefore warranted to fully explore the performance of the 
FilmArray. 
 
In Study four, the performance of the FilmArray BCID panel was evaluated in blood culture 
bottles inoculated with SBF. During the study period, 116 SBF specimens (51 pleural, 38 
synovial, 10 abscesses, 9 dialysis, 7 cerebrospinal, and 1 bile fluid) from 106 patients were 
included. Study four showed a similar performance as study three, where the FilmArray 
identified all microorganisms in 84/92 (91%) bottles with monomicrobial growth, and 18/24 
(75%) specimens with polymicrobial growth when compared with conventional 
identification methods. Among the monomicrobial growth cultures, 8 of the 92 (9%) 
contained microorganisms that were not covered by the FilmArray BCID panel. The clinical 
relevance of these eight microorganisms was not further studied. These microorganisms were 
Bacillus cereus Micrococcus species, and Corynebacterium spo., that are usually considered 
to be contaminants as they are part of normal skin microbiota. In contrast, Actinomyces 
species and Aeromonas species were among the pathogens not included in the panel and may 




Focusing on the microorganisms included in the BCID panel, FilmArray accurately identified 
all 84/84 (100%) microorganisms with monomicrobial growth and 18/24 (75%) 
polymicrobial growth. The study found 100% sensitivity, 100% specificity, and 100% 
negative and 98% positive predictive values for organisms included on the FA BCID panel 
in bottles with monomicrobial growth.  
 
The results from study three and four showed that the FilmArray system has a high sensitivity 
and specificity in detecting microorganisms in both mono-and polymicrobial growth blood 
culture bottles inoculated with SBF including blood. There were samples with 
microorganisms that were not included in the panel. This a common limitation with panel 
based rapid methods. The panel-based rapid methods focus on the most common organisms 
to limit the costs for each pouch used for the analysis. In addition, by limiting the number of 
microorganisms, it is feasible to construct user-friendly systems with a low cost per analysis. 
The major challenge in rapid identification is the ability to identify all microorganisms in 
cultures with polymicrobial growth. Interestingly, this study demonstrated that standard 
culture and identification methods used in clinical microbiology may initially fail to identify 
microorganisms in bottles with polymicrobial growth. The reasons to explain this include the 
overgrowth of rapidly growing microorganisms in relation to slow-growing organisms in the 
same bottles and limited selective agar plates used in routine culture. The combined number 
of polymicrobial growth cultures in both studies were 48. The FilmArray accurately 
identified all microorganisms in 35/48 (72.9%) included in the panel. Similar high 
performance was seen in identification of yeast where the FilmArray could identify 3/3 and 
9/9 yeasts in mono- and polymicrobial growth, respectively. The distinct advantage seen in 
identification of yeast infection is the simultaneous identification of bacteria and antibiotic 
resistance genes more often encountered in immunosuppressed. 
 
Study three and four demonstrates that the FA BCID provides reliable, rapid identification 
results from positive blood culture bottles with SBF including blood. However, the entire 
panel was incompletely assessed due to the limited number of organisms encountered in the 
clinical studies. The FilmArray BCID system should be further evaluated in larger clinical 
studies to fully assess the performance of the panel on all organisms included. The clinical 
impact of the method may be further explored in combining the identification capabilities of 
the FilmArray with antibiotic stewardship programs to assess the hospital costs as well as the 
clinical outcomes.  
 
52 
Despite the impressive results, the FilmArray can only complement conventional culture, 
identification and antibiotic susceptibility testing due to the limited antibiotic susceptibility 
testing and limited number of microorganisms on the BCID panel.   
 
In Study 5, the performance of the ImmuLex S. pneumoniae Omni test was compared with 
two other latex agglutination tests and the BinaxNOW antigen test in blood cultures with 
Gram stain showing Gram positive diplococci. The study showed a high sensitivity of the 
ImmuLex test (99.6 %) that was similar to the Slidex and the Wellcogen tests (99.6 and 100 
%, respectively). When comparing the specificity of the test, the ImmuLex tests had inferior 
specificity to the Slidex test (82.6 % vs. 97.6 %, p < 0.01) had higher but similar to the 
Wellcogen test (85.4 %; p = ns). This study contradicted the previous study performed by the 
manufacturer where the ImmuLex had a specificity of 95%41. 
 
In summary, the study demonstrated that the new ImmuLex test was sensitive but lacked the 
specificity with high rate of false-positive test results in blood cultures with alpha-hemolytic 
streptococci. The number of specimens was sufficient to represent the tests performance. 
Future studies on the clinical impact of these tests would further elucidate the value of the 





6 CONCLUSION  
 
The present thesis showed a shorter TTD in the new Virtuo blood culture system that would 
allow an earlier initiation of microorganism identification. The rapid identification methods 
including FilmArray, MALDI-TOF MS after sub-culture on solid media and the latex 
agglutination tests are all important complements to the conventional culture methods and 
provide early critical information for appropriate antibiotic stewardship. This thesis presented 
an approach to focus on each step in the diagnostic process to decrease the turnaround time 
while maintaining the reliability of the results. The cost of implementing new and improved 
diagnostic system should be weighed against the final goal - patient outcome including 
morbidity and mortality as well as limiting the use of broad-spectrum antimicrobials. A close 
collaboration between the diagnostic microbiology laboratory and the clinical providers is 
encouraged in the management of SBF including blood for rapid diagnosis and 
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